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Cell cycle transitions are driven by oscillations of cyclin-cyclin dependent kinase
(CDK) activity and associated cyclin degradation, mediated by ubiquitylation by
the anaphase-promoting complex (APC). In this work, I analyzed the regulation of
the APC by its activator Cdh1 in budding yeast in single cells. Inactivation of
APC-Cdh1 is an important regulatory transition leading to mitotic entry. I
developed and characterized a fluorescent biosensor to measure the dynamics of
APC-Cdh1 activity in single cells by quantitative time-lapse microscopy. I found
that APC-Cdh1 is inactivated with very reliable timing, in contrast with other cell
cycle events that occur with considerable variability in timing. The activity of APCCdh1 is restrained by multisite phosphorylation by early cyclin-CDKs. Complete
removal of phosphorylation control of Cdh1 results in cell cycle arrest before
mitotic entry, because persistent APC-Cdh1 activity prevents mitotic cyclin gene
expression and accumulation of mitotic cyclins. I show that partial
phosphorylation of Cdh1 allows for partial inactivation of APC-Cdh1. Interestingly,
incompletely restrained APC-Cdh1 activity causes a variable phenotype in cell
cycle progression on the single cell level. This partially penetrant phenotype,
caused by incomplete inactivation of APC-Cdh1, is highly complex; even though

some of the cells arrest in the cell cycle, they occasionally complete later cell
cycle events with delay and in incorrect order. I show that Cdh1 can be
phosphorylated by multiple cyclin-CDKs, and that additional mechanisms of APCCdh1 inactivation besides phosphorylation also contribute to robust inactivation.
In the last part of the thesis, I examine the global cell cycle-associated
transcriptional program and its regulation by cyclin-dependent kinase activity.
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Chapter 1: Introduction

1.1. Regulation of the eukaryotic cell cycle by cyclin-dependent kinases
and the anaphase-promoting complex

The main driver of cell cycle progression is periodic activity of cyclin-dependent
kinases (CDKs) (Morgan, 2007). CDK activity is dependent on its binding
partners, cyclins. Periodic CDK activity is achieved by regulated expression and
degradation of cyclins (Murray, 2004).

In budding yeast Saccharomyces cerevisiae, a well-studied unicellular
eukaryote, a single CDK, named Cdc28, is involved in cell cycle regulation, and
is activated at different cell cycle stages by different cyclins. These cyclin-CDK
complexes promote the events of G1, S-phase and mitosis (figure 1.1) New cells
are born with low CDK activity. Later in the G1, the commitment point, called
Start in budding yeast, signals the decision to commit to a new cell cycle, and is
marked by expression of G1 cyclins Cln1 and 2 (Cross and Tinkelenberg, 1991;
Dirick and Nasmyth, 1991; Richardson et al, 1989; Skotheim et al, 2008). A third
G1 cyclin, Cln3, is present already earlier and has a role in sensing cell size
(Richardson et al, 1989; Wang et al, 2009). Cln-CDK activity promotes
irreversible passage through START and promotes bud emergence. Cln-CDKs
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Figure 1.1: Regulation of cell cycle events in budding yeast.
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are also responsible for phosphorylation of Sic1, a DNA replication inhibitor
(Tyers, 1996). G1 cyclins are highly unstable and Cln-CDK activity drops rapidly
upon transcriptional shutoff of the CLN genes (Schneider et al, 1998). The
second cyclin wave consists of S-phase cyclins, Clb5 and 6, which promote
initiation of DNA replication (Epstein and Cross, 1992; Schwob and Nasmyth,
1993). Onset of mitosis is regulated by yet another set of cyclins, Clb1-4, which
induce a switch from polarized to isotropic bud growth, duplication of the spindle
pole body and formation of mitotic spindle (Amon et al, 1993).

However, in order to complete mitosis, the cyclin-CDK activity must drop, and
the drop in CDK activity is mostly ensured by degradation of cyclins. This is
achieved by ubiquitylation of cyclins by the anaphase-promoting complex (APC;
King et al, 1995; Sudakin et al, 1995). The APC is a multi-subunit protein
complex that requires binding of an activator. There are two homologous
activators, Cdc20 and Cdh1 (also called Hcm1), which provide timing and
specificity (figure 1.2). APC-Cdc20 is active at the metaphase-anaphase
transition. Its targets are Clb5, mitotic cyclins, and importantly also securin
(Pds1), degradation of which is the first step in the cascade leading to cleavage
of cohesin and sister chromatid separation (Cohen-Fix et al, 1996; Shirayama et
al, 1999). APC-Cdh1 is activated later, and its main role is stabilizing the G1
phase and ensuring no premature accumulation of mitotic cyclins. Although it is
not essential for mitotic exit, its targets also include polo kinase Cdc5, various
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components of the mitotic spindle, as well as Cdc20 itself (Hildebrant and Hoyt,
2001; Huang et al, 2001, Schwab et al, 1997).

Another important factor in mitotic exit is phosphatase Cdc14 (Lu and Cross,
2010). Degradation of Clb2 by APC-Cdc20 (Wasch and Cross, 2002) and
release of Cdc14 from the nucleolus (Visintin et al, 1999) causes the kinasephosphatase balance to shift in favor of phosphatase, which drives the mitotic
exit (Drapkin et al, 2009).

The difference in timing of these two activators is ensured by cyclin-CDK activity
(figure 1.2); Cdc20 preferentially binds to CDK-phosphorylated APC and is
therefore active when CDK activity is still high (Rudner and Murray, 2000). In
contrast, activity of APC-Cdh1 is activated by the phosphatase Cdc14
(Zachariae et al, 1998) after the balance between phosphatase and kinase
activity is shifted in favor of phosphatase.

The regulation of the cell cycle by cyclins, cyclin-dependent kinases, as well as
the anaphase-promoting complex and its activators Cdc20 and Cdh1 is
conserved among many eukaryotic lineages, including animals and plants.
However, a recent study of cell cycle regulation in a highly divergent eukaryote,
a human pathogen Giardia intestinalis, has revealed that its genome lacks any
of the APC components. Furthermore, the only B-type cyclin, while degraded
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Figure 1.2: Regulation and targets of the anaphase-promoting complex.
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during mitosis, is not subjected to ubiquitylation (Gourguechon et al, 2013).
Besides this exception, regulation of the cell cycle by cyclin-CDK and the APC is
common to eukaryotes.

1.2. Regulation of APC-Cdh1 in budding yeast

In order to allow for accumulation of APC targets that drive the progression
through the S-phase and entry into mitosis, it is crucial that the APC activity is
restrained after G1-phase. Inactivation of APC-Cdc20 is ensured by its
degradation; its degradation is mediated by both APC-Cdh1, as well as other
mechanisms (Robbins and Cross, 2010b) to ensure that APC-Cdc20 is not
active after the metaphase-anaphase transition. In contrast, activity of APCCdh1 is allowed to persist throughout the G1 phase of the next cell cycle and is
only inactivated upon cell cycle progression through the G1/S transition (Huang
et al, 2001).

The main mechanism of restraining the APC-Cdh1 activity is phosphorylation of
Cdh1 at 11 putative CDK consensus sites. Phosphorylation of Cdh1 reduces the
ability to bind to the APC, as mutation of phosphorylation sites caused
constitutive association of Cdh1 with APC (Zachariae et al, 1998). In addition, it
was also suggested that phosphorylation promotes export of Cdh1 out of the
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nucleus and sequestration from the APC and its substrates. The export is
mediated by a karyopherin Msn5 (Jaquenoud et al, 2002).

It is presently unclear which kinases are responsible for inactivation of APCCdh1. An initial study has suggested that G1 cyclins are responsible for
inactivation of APC-Cdh1 activity (Amon et al, 1993). Later, it was suggested
that Cln-CDKs are not sufficient for APC-Cdh1 inactivation, and Clb3,4,5-CDK
are required (Yeong et al, 2001). However, the results of both of these studies
were based on stability of ectopically expressed mitotic cyclin Clb2, which is also
a negative regulator of APC-Cdh1 in addition to being an APC-Cdh1 substrate.
A subsequent study used an inert reporter for APC-Cdh1 activity and found that
Clb5 and 6-CDK are responsible for proper timing of APC-Cdh1 inactivation,
although APC-Cdh1 inactivation still occurred in absence of Clb5 and 6 (Huang
et al, 2001).

Other mechanisms might contribute to APC-Cdh1 inactivation. It was found by
mass spectrometry that Cdh1 is phosphorylated at many other residues, which
might have regulatory effects (Hall et al, 2004). It was suggested that
phosphorylation of Cdh1 by both CDK as well as polo kinase Cdc5 is required
for mitotic spindle assembly (Crasta et al, 2008), although mutation of Cdc5
binding sites on Cdh1 was later shown to have no regulatory effects (Robbins
and Cross, 2010a). In addition, recognition of substrates by APC-Cdh1 is
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blocked by a pseudosubstrate inhibitor Acm1 (Martinez et al, 2006), however,
deletion of ACM1 does not have any major effects and inhibition by Acm1
probably plays a relatively minor role. Remarkably, Cdh1 abundance is not
significantly regulated by cell cycle-specific expression or degradation and is
constant throughout the cell cycle.

Regulation of Cdh1 by multisite phosphorylation is conserved in vertebrates,
although the precise localization of phosphorylation sites varies. A stoichiometric
inhibitor Emi1 also exists and is regulated in a similar fashion to stabilize mitotic
cyclins in interphase and couple DNA replication with mitosis (Di Fiore and
Pines, 2007). However, unlike yeast where Cdh1 is stable (Zachariae et al,
1998), Cdh1 is degraded in S-phase by the SCF ubiquitin ligase in mammalian
cells (Benmaamar and Pagano, 2005).

A careful study by using exact gene replacements found that
unphosphorylatable CDH1-m11 allele is incompatible with viability (Robbins and
Cross, 2010a). Phosphorylation of Cdh1 by CDK is therefore essential for cell
cycle progression. Specifically, CDH1-m11 cells arrest at the G2/M border, with
replicated DNA, but before switching to depolarized bud growth and formation of
the mitotic spindle. Introducing non-degradable mitotic cyclin Clb2-kd in CDH1m11 cells restored the ability to form spindles and depolarize growth, which
indicates that in particular restraining the degradation of mitotic cyclins, but not
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necessarily other APC-Cdh1 targets, is the main requirement for APC-Cdh1
inactivation (Robbins and Cross, 2010a).

1.3. Multisite phosphorylation in regulation of CDK substrates

Global mapping of CDK substrates in budding yeast has revealed that a large
fraction of CDK phosphoproteome consists of substrates that contain multiple
CDK phosphorylation sites per protein (Holt et al, 2009). Interestingly, the
precise position of these phosphorylation sites is poorly conserved in orthologs
in related fungal species. The majority of these sites are found in unstructured
regions of proteins and loops. This implies that regulation of these substrates by
multisite phosphorylation might often depends on rather non-specific
mechanisms that disrupt or enhance protein interactions by adding bulk negative
charge on the protein surface (Holt et al, 2009).

Regulation of proteins by multisite phosphorylation has been studied on multiple
substrates. An example of regulation by bulk negative charge is Ste5, a scaffold
protein involved in MAP kinase signaling in response to mating pheromone.
Ste5 is inactivated by Cln-CDK by disrupting its membrane localization
(Strickfaden et al, 2007). This is achieved by phosphorylation on a cluster of
sites in a basic motif that can bind the plasma membrane. Disruption of
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membrane binding requires a large number of negative charges, which is
achieved by 8 phosphorylation sites in the plasma membrane binding domain of
Ste5 (Strickfaden et al, 2007).

The mechanistically best-understood example of multisite phosphorylation is
Sic1, the stoichiometric inhibitor of mitotic cyclin-CDK. Upon phosphorylation,
Sic1 is recognized by the SCF ubiquitin ligase and targeted for degradation. An
initial study has proposed a “counting mechanism”, in which recognition of the
phosphodegron on Sic1 by the SCF ubiquitin ligase is dependent on exactly 6
phosphate groups (Nash et al, 2001). Such mechanism can ensure both a delay
as well as a sharp transition, as shown experimentally as well as by a
mathematical model (Deshaies and Ferrell, 2001). However, the requirement for
six phosphorylation sites was difficult to reconcile with the structure of the
human homolog of the SCF bound to cyclin E peptides, where a tight interaction
was observed with just a doubly phosphorylated degron (Hao et al, 2007).
Subsequently, in sharp contrast to the counting mechanism, a careful
biochemical analysis of multisite phosphorylation of Sic1 has revealed an
ordered cascade of processive phosphorylation events, initiated by G1 cyclins
and then carried out mostly by S-phase cyclin-CDKs (Koivomagi et al, 2011).

Multisite phosphorylation can in principle generate nonlinearity by multiple
mechanisms, and such nonlinearity can contribute to generating sharp
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transitions between cell cycle stages. Experimentally, nonlinearity was observed
and characterized in Xenopus Wee1 (Kim and Ferrell, 2007). Nonlinear
response to kinase levels in Wee1 arises through a substrate competition
mechanism. Phosphorylation of one critical residue, T150, in Wee1 is highly
ultransensitive with response to cyclin B-Cdk1. This nonlinearity arises due to
competition with phosphorylation at other inessential kinase sites on Wee1, as
well as other high affinity Cdk1 targets (Kim and Ferrell, 2007).

Different phosphorylation sites on the same protein can in principle have
different functions. Such a mechanism was described in a budding yeast
transcription Pho4, which is phosphorylated by another cyclin-cyclin dependent
kinase Pho80/Pho85. Of four phosphorylation sites located on Pho4,
phosphorylation at two of the sites promotes nuclear export; phosphorylation at
the third site inhibits nuclear import; and phosphorylation at the fourth site
prevents association with a binding partner Pho2 (Komeili and OʼShea, 1999). It
is an intriguing possibility that such separable roles of different phosphorylation
sites might also exist in CDK substrates.
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1.4. Cell cycle-regulated gene expression

In parallel to the biochemical oscillator, driven by CDK activity and ubiquitylation,
periodic gene transcription also contributes significantly to the cell cycle control.
A pioneering study in the late 1990s using the emerging microarray technology
has revealed that a significant fraction of yeast genome undergoes cell cycle
regulated transcription (Spellman et al, 1998). Overall, about 800-1200 genes
(out of ~6400 total) are thought to be statistically significantly upregulated at a
certain cell cycle stage (Spellman et al, 1998; Orlando et al, 2008; Pramila et al,
2006; de Lichtenberg et al, 2005). This periodic gene expression is ensured by
activity of particular transcriptional factors at different cell cycle stages.

There are three main clusters of gene expression. Transcriptional factors SBF
and MBF activate transcription of genes at the G1/S border (Dirick et al, 1992).
Among genes in this regulon are G1 cyclins and S-phase cyclins. The second
cluster, regulated by transcription factors Mcm1, Fkh1/2 and Ndd1, activates
expression of genes at the G2/M border (Koranda et al, 2000). These genes
include mitotic cyclins, as well as Cdc20. The third cluster is activated at the
mitotic exit, and is regulated by transcription factors Swi5 and Ace2 (ColmanLerner et al, 2001; Knapp et al, 1996). A few other clusters that contain a
smaller number of genes, such as the S-phase cluster regulated by Hcm1
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(Pramila et al, 2006), and the histone cluster (Dollard et al, 1994), also contain
cell cycle-regulated genes.

It was generally assumed that the activity of these transcription factors is
regulated by CDK phosphorylation (or dephosphorylation) and that periodic
transcription is therefore downstream of the CDK oscillator. However, a
genome-wide study has found that upon depletion of B-type cyclins, cells enter a
cell cycle arrest, but the majority of the periodic transcriptome continues to
oscillate (Orlando et al, 2008). This hinted that an oscillatory mechanism that is
independent of B-type cyclin-CDK activity could sustain periodic transcription.
Further study has suggested that even in complete absence of CDK activity,
periodic transcription is still present (Simmons-Kovacs et al, 2012). The authors
have proposed a model of a transcriptional oscillator, based on sequential
activation of transcription factors (Orlando et al, 2008, Simmons-Kovacs et al,
2012). A recent study has proposed that the transcriptional oscillator is stalled
when checkpoints are activated (Bristow et al, 2014). It remains unresolved if,
and to what extent, periodic gene expression is in fact regulated by periodic
cyclin-CDK activity, and to what extent other CDK-independent mechanisms can
drive periodic regulation of cell cycle-regulated genes.
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1.5. Cell-to-cell variability and effects of molecular noise

Clonal populations of cells can exhibit striking cell-to-cell variability. Expression
levels of a gene can vary greatly between genetically identical cells grown in
identical environment (Elowitz et al, 2002). Single cell methods to measure
protein abundance in single budding yeast cells have showed great variability in
abundance of the proteome in budding yeast (Newman et al, 2006). On the level
of mRNA, counting single mRNA molecules has revealed substantial variation in
number of mRNA molecules per cell (Zenklusen et al, 2008).

This heterogeneity is generally assumed to have no functional significance
(reviewed in Altschuler and Wu, 2010). In fact, mechanisms specifically aimed to
suppress noise have evolved. For example, in budding yeast cell cycle, an
active mechanism of noise suppression was found in the Start transition, where
coherence regulatory program was carefully measured in single cells (Bean et
al, 2006). Deletion of SWI4, the component of the transcription factor SBF,
greatly reduced specifically the cell-to-cell variability in coherence of Start events
(time budding and CLN2 expression peak), but not the mean duration of the
interval, consistent with existence of complex mechanisms for noise
suppression. The remaining cell-to-cell variability observed in budding yeast
Start is perhaps represents a compromise between high coherence of events
and high regularity in timing (Bean et al, 2006).
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However, in some cases, cells can exploit molecular noise to stochastically
generate different transient phenotypic states. So far, these phenomena have
mostly been studied in bacteria. For instance, in Bacillus subtilis, a fraction of
cells can transiently switch to a competent state, during which they can
potentially take up foreign DNA from the environment, at the expense of slowing
the growth rate. The switching is driven by molecular noise in expression of the
regulator (Maamar et al, 2007; Cagatay et al, 2009). A similar phenomenon is
seen in Escherichia coli, where a small fraction of cells transiently enters a slow
growing “persister” state, in which they are less sensitive to lethal doses of
antibiotics (Balaban et al, 2004). Such phenomena are seen as bet hedging; the
population sacrifices its fitness to gain phenotypic diversity, which increases the
chance of survival in unpredictable environments. Bet hedging can provide an
advantageous strategy for survival to simple sensing and responding to changes
in environment (Kussell and Leibler, 2007).

A possibly related phenomenon was recently also observed in budding yeast.
High throughput imaging has revealed that clonal populations of yeast cells
exhibit a range of growth rates (Levy et al, 2012) in a heritable manner. It was
found that slower growth correlates with resistance to heat killing and correlates
with age. While the significance of this phenomenon is not yet fully understood,
it might be another example of a similar bet-hedging strategy that could ensure
population survival in unpredictable environments (Levy et al, 2012).
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In the budding yeast cell cycle, duration of various events of cell cycle differs
substantially between cells. Much of this variability is accounted for by the
duration of G1 phase (Lord and Wheals, 1981). The variability of G1 phase can
be partially attributed to molecular noise; coefficient of variation of the duration of
the unbudded period of the cell cycle (cytokinesis to bud emergence) scales with
the square root of ploidy, suggesting that molecular noise in gene expression is
an important source of variability in G1 phase (Di Talia et al, 2007). However,
additional element controlling the variability of the duration of G1 is cell size at
birth in daughter cells. Due to asymmetric cell division, daughter cells are born
smaller and more variable in size. Since cell size control is executed in G1, the
duration of the G1 phase in daughters is also highly dependent on cell size at
birth (Di Talia et al, 2007). In contrast, little is understood about variability of the
duration of the budded period of the cell cycle, which is also significantly
variable.

1.6. Rationale for the present study and organization of the thesis

The aim of the present study was to gain understanding into the variability of the
budding yeast cell cycle and regulation of Cdh1 inhibition by multisite
phosphorylation. As outlined above, many questions about regulation of APC-
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Cdh1 remain unresolved, and understanding the regulation of proteins by
multisite phosphorylation is of significant general interest.

All the work was done in the budding yeast Saccharomyces cerevisiae. In
chapter 2, I focus on development of a quantitative assay to measure the
dynamics of APC-Cdh1 activity in single cells, and address the cell-to-cell
variability of timing of cell cycle events leading to entry into mitosis. In
subsequent chapters 3 and 4, I then focus on regulation of Cdh1. In chapter 3, I
address the regulation of APC-Cdh1 by multisite phosphorylation by generating
partially phosphorylatable CDH1 mutants and analyzing their phenotype. In
chapter 4, I focus on the relationship and hierarchy between regulators of Cdh1.
Chapter 5, experimental part of which was done in collaboration with S. Jamal
Rahi and Kresti Pecani, is a departure from the topic of the rest of this thesis,
and is an analysis of the genome-wide pattern of cell cycle-regulated gene
expression, also in Saccharomyces cerevisiae. Chapter 6 is a discussion of the
main findings of the work presented in the thesis.
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Chapter 2: Timing of mitotic entry events

2.1. Variability of duration of the budded period of the budding yeast cell
cycle

The budded period of the cell cycle (time from bud emergence to cytokinesis) is
variable (Di Talia et al, 2007; figure 2.1). In contrast to the G1 period, the
variability does not scale with ploidy, ruling out the molecular noise in gene
expression as a simple explanation (Di Talia et al, 2007). The variability is also
not accounted for by sporadic activation of checkpoints, since deleting both the
components of the spindle assembly checkpoint and DNA damage checkpoint at
once does not reduce the variability (F. Cross, unpublished data).

The budded period of the cell cycle involves multiple crucial cell cycle events
and independent regulatory steps, and it remains unexplored how variable each
of these steps are. In this chapter, I focused on developing tools to assess the
timing and variability of regulatory events leading to entry into mitosis,
inactivation of APC-Cdh1 and activation of expression of the mitotic cyclin CLB2.
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Figure 2.1: Variability of the budded period in the budding yeast cell cycle. A
histogram of durations of the cell cycle period from budding to cytokinesis, as
measured by presence of the bud neck marker Myo1-mCherry signal at the
bud neck.
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2.2. Development of a biosensor for APC-Cdh1 activity

In order to precisely measure the variability in inactivation of APC-Cdh1, I
sought to develop a fluorescent biosensor that would be sensitive to degradation
regulated by ubiquitylation by APC-Cdh1. An ideal biosensor would be inert and
degraded exclusively by APC-Cdh1.

Based on these considerations, I constructed the biosensor using a C-terminal
fragment of Ase1, a spindle protein (Juang et al, 1997). Unlike many other APC
targets that are ubiquitylated by both APC-Cdc20 and APC-Cdh1, Ase1 is
strongly destabilized by APC-Cdh1, but is not significantly destabilized by APCCdc20 (Visintin et al, 1997). Previous studies have also determined the minimal
Ase1 fragment necessary and sufficient for degradation and established that this
fragment does not interfere with any cellular processes (Huang et al, 2001).

The construct encoded the C-terminal fragment of Ase1 sufficient for APC-Cdh1
degradation (amino acid residues 632-885) fused to a yellow fluorescent protein
yVenus and placed the construct under control of the MET3 promoter (figure 2.2
A). MET3 promoter is repressed by methionine in the media and expressed in
absence of methionine. Expression from the MET3 promoter has been shown to
be stable throughout the cell cycle (Charvin et al, 2008).
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Figure 2.2: A biosensor for APC-Cdh1 activity. A) A scheme of the
biosensor construct. The construct is composed of a fusion of a yellow
fluorescent protein (yVenus) and the C-terminal sequence of Ase1.
Expression of the construct is driven by the methionine-repressible
promoter MET3pr. B) Combined phase-contrast and fluorescence images
from the time-lapse video of a representative wild-type cell expressing the
biosensor (yellow) and a bud-neck marker Myo1-mCherry in red. C)
Quantification of mean cellular fluorescence in a representative cell
expressing the biosensor. Open circles: raw data, solid line: smoothing
spline fit. D) Quantification of total nuclear fluorescence in a representative
cell. Black lines represent nuclear division, and dashed line is the sum of
the fluorescence in the mother and daughter nucleus.
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The cells carrying the biosensor exhibited once per cell cycle oscillations in
yVenus fluorescence (figure 2.2 B). To quantitatively assess these oscillations, I
quantified mean cell fluorescence by using the semi-automated image
segmentation software (Charvin et al, 2008). The fluorescence begins to rise
around the time of bud emergence, and conversely, fluorescence begins to drop
before cytokinesis (figure 2.2 C). These oscillations of fluorescence are due cell
cycle-regulated stability of the biosensor by APC-Cdh1. However, an effect,
owing to the fact that the biosensor is localized in the nucleus, contributes to the
mean fluorescence of the cell. At the time of the nuclear division, half of the
amount of the biosensor was lost to the nascent daughter cell during the nuclear
migration and division (and was excluded in quantification of the mother cell),
resulting in a drop of fluorescence in the mother cell. Since APC-Cdh1 activity is
present at mitotic exit, the timing of these two effects is somewhat overlapping.

To account for that effect due to nuclear division and demonstrate that
degradation of the biosensor indeed takes place, I quantified the total
fluorescence of the nucleus, corresponding to the total amount of the biosensor
(figure 2.2 D). To account for fluorescence loss at nuclear division, I then
summed up the fluorescence of the mother and daughter cells after nuclear
division (dashed lines). The total fluorescence still dropped after the nuclear
division, indicating that biosensor was degraded after nuclear division. However,
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the dynamic range of oscillations was reduced if the dilution of fluorescence due
to nuclear division was taken into account.

It needs to be noted that the gradual rise and fall, rather than sharp transitions in
fluorescence levels, are due to slow maturation time of fluorescent proteins; first
order constant for maturation of yVenus in budding yeast was measured to be
around 20 minutes (Charvin et al, 2008). Assigning precise transition times from
such gradual changes poses a problem. I tackle this issue later in this chapter; I
note that the problem is analogous to determining turn-on times of promoters,
which are likewise masked by identical dynamics of slow fluorescent protein
maturations (Skotheim et al, 2008).

2.3. Oscillations in biosensor stability are due to APC-Cdh1 activity

First, I sought to establish whether constant activity of APC-Cdh1 is sufficient for
complete biosensor degradation. To do so, I measured the biosensor dynamics
in cells lacking the ability to inhibit APC-Cdh1 activity. I used an
unphosphorylatable and therefore constitutively active allele of CDH1, CDH1m11, that lacks all 11 CDK phosphorylation sites (Robbins and Cross, 2010a;
Zachariae et al, 1998). CDH1-m11 is lethal, but cells can be conditionally kept
alive by overexpressing ACM1, the stoichiometric inhibitor of APC-Cdh1, from a
galactose-inducible promoter. Upon switch to glucose to turn off GAL-ACM1,
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CDH1-m11 cells arrested at mitotic entry. In these arrested cells, the biosensor
fluorescence was very low and constant (figure 2.3 B,C). The constant
fluorescence indicates a steady state with balanced synthesis and high
degradation rate, as the expression from MET3 promoter persists during the
arrest. This result indicates that constitutive activity of APC-Cdh1 is sufficient for
constant high degradation rate of the biosensor.

I then sought to establish whether Cdh1 is solely responsible for cell cycleregulated degradation of the biosensor. To do that, I examined the dynamics of
the biosensor in cells lacking APC-Cdh1 activity. cdh1 cells are viable and do
not exhibit any major cell cycle defects. Quantified as mean fluorescence within
the entire cell boundary (excluding the bud), the biosensor fluorescence was
substantially (three-fold) elevated throughout the cell cycle compared to wild
type, indicating an overall lower degradation rate in these cells (figure 2.3 C).
Therefore, APC-Cdh1 contributes to degradation of the biosensor.

However, quantifying the fluorescence as mean fluorescence within the entire
cell still results in oscillations during the cell cycle, with fluorescence dropping
precipitously at the time just before cytokinesis (figure 2.3 A). This is due to the
nuclear localization effect, described above. To account for that, I instead
quantified the total fluorescence of the nucleus in cdh1 cells (figure 2.3 D),
similarly as done above for wild type cells (figure 2.2 D). The sum of
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Figure 2.3: APC-Cdh1 is responsible for oscillations in biosensor
fluorescence. A) Representative traces of biosensor fluorescence in cdh1
cells, along with a wild type cells (dashed line). B) Representative traces of
biosensor fluorescence in CDH1-m11 cells. C) Quantification of normalized
average fluorescence levels. D) Representative traces of biosensor
fluorescence in cdc20 cells. Fluorescence values shown in these plots were
corrected for autofluorescence by subtracting fluorescence values of
unlabeled cells.
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fluorescence of the mother and daughter nuclei after nuclear division resulted in
a linear rising trend, consistent with constant synthesis of the biosensor, in most
cell cycles (71% of cell cycles; example cycle 1 in figure 3.3 D). Only in a
minority of cell cycles (29%) the summed fluorescence of the mother and
daughter nuclei exhibited a slight drop. This effect could be attributed to image
analysis, since the total fluorescence intensity of the nucleus is difficult to
quantify due to changing shape of the nucleus during the division.

2.4. Determining the timing of APC-Cdh1 inactivation in single cells

In this work, I wanted to develop a method to determine the time of inactivation
of APC-Cdh1. However, this problem is challenging because slow maturation
time of fluorescent proteins masks the sharpness of transitions. The problem is
analogous to examining promoter turn-on times, for which tools already exist
(Skotheim et al, 2008; Eser et al, 2011).

Previously, the maximum of the second derivative of the smoothing spline fit
was used for determining the turn-on time for a promoter (Skotheim et al, 2008).
However, for the biosensor data, it turned out that the second derivative method
is particularly sensitive to noise in fluorescence measurements (see chapter
2.6). Subsequently, a method for determining the turn-on times from where the

26

first derivative reaches 10% of the maximum value has been used (Eser et al,
2011), as it was shown that this method provides higher reproducibility between
datasets (Jan Skotheim, personal communication).

I measured the APC-Cdh1 turn-off times from the fluorescence time series
quantified as mean cell fluorescence. Since the nucleus is divided earlier in the
cell cycle, the effect of the nuclear division does not interfere with the
determination of APC-Cdh1 inactivation time. In order to assign a sharp timing of
the APC-Cdh1 inactivation from the data with gradual rise of fluorescence, the
time point at which the first derivative of the smoothing spline fit changed from
negative to positive (i.e. where the slope turns upwards) was chosen to be
assigned as the APC-Cdh1 turnoff time. I note that the method used here is
essentially equivalent to the 10% of the maximum of the first derivative method,
since the first derivative of APC-Cdh1 biosensor traces typically reaches about
10% around the first frame after the fluorescence minimum (figure 2.5); therefore
the difference between the results of these two methods would be smaller than
the sampling interval.
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Figure 2.4: A first derivative-based method for detection of APC-Cdh1
inactivation time. Bold blue line: a smoothing spline fit of a fluorescence trace
as shown in 2.2. Red line: first derivative of the fluorescence trace, computed
as difference between fluorescence values at two adjacent time points. Black
stars: points of the transition as determined by the algorithm. The points
where the first derivative transitioned to positive represent APC-Cdh1
inactivation times.
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2.5. Measuring the contribution of measurement error to the timing of
APC-Cdh1 inactivation

It is unclear to what extent the determination of the measured inactivation time is
governed by the noise. The fluorescence intensities measured from images vary
considerably between frames, and the noise at particular time points could
strongly affect the exact shape of the smoothing spline fit, the first derivative
function, and the measurement of the APC-Cdh1 inactivation time.

To estimate the noise, I calculated the difference between the raw data value
and the value of the corresponding fit at each data point of the curve. The
distribution of the difference is uniform throughout the time course and follows a
roughly normal distribution (figure 2.5, panels A,B).

I then added normally distributed noise (with the same standard deviation as the
SD for the difference between the raw data and smoothing spline fit) to the
smoothing spline fit (figure 2.5 C). This generated simulated data with equal
degree of noisiness as the raw data. Then, I fitted the simulated data with a
smoothing spline, and determined the apparent APC-Cdh1 inactivation time
from the fitted simulated data using the first derivative method.
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Figure 2.5: Estimation of measurement noise in inactivation time. A,B) The
distribution of the difference between the raw data and the smoothing spline
fit. C) The procedure for generating simulated data. Raw data (thin blue line)
was fitted with the smoothing spline (bold blue line). Subsequently, random
noise with the standard deviation of the distribution in B was added (thin red
line). Simulated data was then fitted again with the smoothing spline (bold red
line) and inactivation times were determined as in 2.4. D,E) Examples of
fluorescence traces for two cell cycles. Blue line, smoothing spline fit; blue
dots, raw data. Inset, the distributions of measurement error in APC-Cdh1
inactivation, defined as the difference in time measured from the simulated
data and the time measured from the experimental data, by generating the
simulated data 50 times. The data for the cell in D) represent a noiseresistant measurement. The measurement for the cell in E) is sensitive to
noise, and was discarded.
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The difference between the time of inactivation measured from the fit of the
simulated data and the time of inactivation measured from the original fit
represents the measurement error. For each cell, I performed the procedure
multiple times to obtain a distribution of the apparent APC-Cdh1 inactivation
measurement error (figure 2.5 D,E). I define the mean of the measurement error
(MME) to be the mean of this distribution, and the standard deviation of the
measurement error (SDME) to be the standard deviation of this distribution.

For most cells, the distribution of measurement error was tight and centered
around 0 (figure 2.5 D). However, a fraction of measured cells was found to be
sensitive to noise, as the SDME was significantly bigger than zero (indicating a
great dependence of the measurement to noisy time points), and/or the MME
differed greatly from zero (indicating a systematic shift in the measurement of
APC-Cdh1 inactivation; figure 2.5 E). The fluorescence traces of these cells
typically had a less sharp transition, which could be due to some noisy time
points around the time of transition (figure 2.5 E). The apparent APC-Cdh1
inactivation time from these cell cycles therefore does not represent an accurate
measurement of the biological event. To avoid contaminating the measurement
of cell-to-cell variability with potentially noisy data points, I excluded cell cycles
in which the MME was greater than 3 minutes, or in which the SDME was
greater than 3 minutes. By using this procedure, I therefore limited the
contribution of the measurement error to the standard deviation to maximum 3
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minutes, and the rest of the measured standard deviation therefore likely reflects
biological variability. The 3 minutes cutoff is equal to the imaging frequency in
the experiment; therefore detection of events on a shorter time scale in this
experiment is impossible.

I note that exclusion of a fraction of cells might potentially introduce a bias,
because it is possible that these excluded cells might include a population of
biologically different cells, for instance cells in which APC-Cdh1 inactivation was
less sharp. However, the number of excluded cells in the experiments was only
10-20% (table 2.1), and the excluded cells looked morphologically normal and
had overall similar cell cycle times.

2.6. Variability in timing of APC-Cdh1 inactivation

Using a strain that harbored a fluorescently labeled Myo1-mCherry as a bud
neck marker in addition to the APC-Cdh1 biosensor, I measured the time of
APC-Cdh1 inactivation with respect to budding. On average, Cdh1 was
inactivated 4 minutes before budding (figure 2.6 A). However, even after
removing the noisy data points using the procedure described above, there was
a considerable variability between cells, likely representing biological cell-to-cell
variability in coherence between these two events. This poor coherence
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between budding and APC-Cdh1 inactivation could be due to variability in APCCdh1 inactivation times, variability in timing of bud emergence (already known to
be variable (Di Talia et al, 2007)), or both.

To measure the timing of APC-Cdh1 inactivation with respect to relevant
regulatory steps, I constructed a strain carrying both the APC-Cdh1 biosensor,
as well as a GFP-tagged Whi5 protein. Whi5 is a transcriptional repressor that
controls the passage through Start, the commitment point in the budding yeast
cell cycle. Whi5 directly represses the G1/S transcriptional regulon, which
includes all of the regulators of Cdh1 – CLN1,2, CLB5,6 and ACM1. Upon
phosphorylation of Whi5, the repression is lifted and the G1/S regulon
transcription can occur. At the same time, Whi5 localization sharply changes
from nuclear to cytoplasmic, which can be followed by time-lapse microscopy.

APC-Cdh1 inactivation occurred 12 minutes after Whi5 nuclear exit (figure 2.6
B), and variability between cells is considerably smaller than when measured
with respect to Whi5 exit than to budding. The standard deviation is only 3
minutes, which is equal to the upper estimate of the fitting error. Since the frame
rate in the experiment was also 3 minutes, and that measurement of Whi5 exit is
limited by this estimate, the measurement effectively limits the variability to one
frame. Therefore, I cannot exclude that there might not be any biological
variability between cells at all.
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Figure 2.6: Timing of APC-Cdh1 inactivation with respect to cell cycle events.
A) A histogram of times from budding to APC-Cdh1 inactivation. B) A
histogram of times from Whi5 nuclear exit to APC-Cdh1 inactivation. C) A
histogram of times from APC-Cdh1 inactivation to cytokinesis. Each data
point represents a measurement from one single cell. The data points that
were sensitive to noise are excluded.
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I also measured the time of APC-Cdh1 inactivation with respect to subsequent
cytokinesis (detected by disappearance of the Myo1-mCherry signal at the bud
neck; figure 2.6 C). Compared to the variability of the time from budding to
cytokinesis, APC-Cdh1 inactivation occurred with similar variability (table 2.1). It
is therefore likely that the timing of APC-Cdh1 inactivation is not the crucial
factor in the post-budding variability in the cell cycle timing.

2.7. Variability in timing of CLB2 promoter activation

I measured the timing of another event leading to entry into mitosis, activation of
CLB2 promoter. Accumulation of the mitotic cyclin Clb2 requires APC-Cdh1
inactivation (Robbins and Cross, 2010a). The expression of mitotic cyclin genes
is cell cycle-regulated; the CLB2 gene belongs to the CLB2 cluster (Spellman et
al, 1998). It is believed that mitotic cyclin-CDK activity is required for full
activation of CLB2 (Amon et al, 1993). Consistent with the existence of such
positive feedback loop, I show later in this work that inactivation of APC-Cdh1 is
required for CLB2 promoter expression, as cells bearing constitutively active
CDH1-m11 do not activate the CLB2pr (chapter 3.8). It is therefore expected
that induction of CLB2 expression occurs after APC-Cdh1 inactivation.
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Figure 2.7: Timing of CLB2pr induction. A histogram of times from CLB2pr
induction to cytokinesis.

37

To measure the time of induction of CLB2 promoter, I used a construct of CLB2
promoter driving the expression of unstable GFP (Skotheim et al, 2008). The
strain also harbored the MYO1-mCherry bud neck marker for detection of
cytokinesis.

Using these two markers, I measured the time from CLB2pr activation to
subsequent cytokinesis. I determined the CLB2pr activation time using the same
first derivative-based detection method, and applied the same procedure as
used for the APC-Cdh1 biosensor to address the dependence of each data point
to noise (see chapter 2.5). The CLB2pr-GFP signal exhibits a lower dynamic
range; as a result, the measurements of induction times from the first derivative
sign switch in this experiment were more dependent on noise. I included data
points from cell cycles for which both the MME and SDME were less than 4.5
minutes (as opposed to 3 min for the APC-Cdh1 biosensor experiments). This
causes a bigger residual error in these measurements.

On average, CLB2pr activation occurred later than APC-Cdh1 inactivation
(comparing both events with respect to cytokinesis; figure 2.7, table 2.1). In
addition, the timing of the interval from CLB2pr inactivation to cytokinesis is
variable. This raises the possibility that the entire variability of the post-Start
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period of the cell cycle could be accounted for by variability of events after
CLB2pr induction.

2.8. Conclusions and future directions

In this chapter, I focused on developing experimental tools and data analysis
procedures to measure the timing of cell cycle events that lead to entry into
mitosis. These tools enabled quantitative measurement of cell-to-cell variability
of these events. This work was motivated by the fact that variability of the
duration of the cell cycle period after budding is not understood. I therefore
sought to measure the durations of various sub-periods, with the idea that
finding sub-periods of the cell cycle that are not variable in timing would allow
me to narrow down the cell cycle events that are responsible for generating
variability.

In general, variability of timing of different events is different to compare
because of technical error; biological variability is masked by measurement
variability. The detection of events is limited by sampling resolution (3 minutes in
all experiments presented here) and is additionally increased for events of which
timing was extrapolated by the first derivative method. This causes a technical
error in the measurements. In general, a useful parameter for comparison of
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variability for events with different average durations is coefficient of variation
(CV; ratio of standard deviation (SD) over mean), because it takes into account
the average duration of events. However, technical variability due to sampling
resolution is independent of the mean, and therefore affects longer events less
than shorter events (assuming equal CV). CV is therefore only useful for
comparing longer events. In contrast, for shorter events, comparing SD
(assuming the technical error is the same for both events) might be more useful.
However, this comparison is only valid for events of equal mean duration.

The findings are schematically summarized in figure 2.8. Timing of bud
emergence is independent of all other events, since budding is regulatorily
decoupled from other events assessed here. Therefore, the relevant reference
point for measurements is Whi5 exit, which marks the Start transition. Start is
the major regulatory step that controls both bud emergence and APC-Cdh1
inactivation. The timing of bud emergence with respect to Start is variable (Di
Talia et al, 2007; table 2.1) and ploidy dependent, suggesting that it is affected
by molecular noise in gene expression (Di Talia et al, 2007). In contrast to
budding, the timing of APC-Cdh1 inactivation was found to be invariable with
respect to Start (table 2.1). I did not test whether the variability in timing of APCCdh1 inactivation is ploidy-dependent. The standard deviation reported for the
interval from Whi5 exit to APC-Cdh1 inactivation is an overestimation of the
actual biological variability, because it still includes the remaining measurement
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error in APC-Cdh1 inactivation (the upper limit is 3 minutes) as well as error in
detection of Whi5 exit, which is limited by the imaging interval (also 3 minutes).
Given these technical constraints, the contribution of (biological) cell-to-cell
variability might be as low as zero. This is in contrast to the variability of APCCdh1 inactivation with respect to budding, which on average occurs at almost
the same time, but has considerable cell-to-cell variability.

Inactivation of APC-Cdh1 depends on multiple genes expressed from the G1/S
regulon: CLN1,2, CLB5,6 and ACM1 are all SBF and MBF targets. CLN2
promoter expression is almost concurrent with Whi5 exit, measured in single
cells (Skotheim et al, 2008). Expression of most other members of the regulon
occurs later than CLN2 (Eser et al, 2011), but can be expected to be expressed
with little cell-to-cell variability in timing (like CLN2), although no single cell data
exists for the particular APC-Cdh1 regulator genes. Deletion of WHI5 advances
expression of the regulon (Skotheim et al, 2008); it would be interesting to
assess whether it also advances APC-Cdh1 inactivation. Furthermore, to test
whether the timing of APC-Cdh1 inactivation is dependent specifically on SBF or
MBF-regulated transcripts, it would be interested to measure the time of APCCdh1 inactivation in cells where either MBF or SBF are removed by deleting the
DNA-binding domains of those transcription factors, MBP1 and SWI4,
respectively.
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Event

Mean
(min)

SD
(min)

CV

0.19
1.5

Number
of cells
measured
74
49

Number
of cells
excluded
0
6

Bud emergence to cytokinesis
Bud emergence to APC-Cdh1
inactivation
Whi5 exit to APC-Cdh1
inactivation
APC-Cdh1 inactivation to
cytokinesis
CLB2pr activation to
cytokinesis
Whi5 exit to bud emergence

58
-4

11
6

12

3

0.25

31

10

67

14

0.21

30

5

52

11

0.21

37

15

23

10

0.43

66

0

Table 2.1: Summary of the data from chapter 2. The last column is the
number of cells that were excluded from the measurement due to sensitivity
to experimental noise.

Figure 2.8: Variability in cell cycle events. A schematic representation of the
findings in this chapter, in combination with results from Di Talia et al, 2007 and
Skotheim et al, 2008. The dotted lines represent intervals that show
considerable cell-to-cell variability in duration; solid lines represent cell-to-cell
invariable intervals. The question mark represents a hypothesized invariable
interval (see text). Blue arrows are known regulatory nodes.
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Another event of interest is activation of APC-Cdh1 at mitotic exit. APC-Cdh1 is
activated by dephosphorylation by phosphatase Cdc14 (Visintin et al, 1997; Lu
and Cross, 2010). The timing of Whi5 nuclear entry, which is also regulated by
Cdc14 dephosphorylation of Whi5, was measured to occur 6 minutes before
cytokinesis with little or no cell-to-cell variability (Di Talia et al, 2007; K. Pecani,
unpublished data), and it is likely that APC-Cdh1 is activated with similar
dynamics. Measuring the timing of APC-Cdh1 activation would have to take into
account the drop in fluorescence due to nuclear division (which occurs at around
the same time).

I also examined the timing of activation of CLB2 promoter. The cell-to-cell
variability in time from CLB2pr induction to cytokinesis is equal to the variability
of time from budding to cytokinesis. Therefore, the entire variability of the
budded period of the cell cycle can be explained by the variability from CLB2pr
activation to cytokinesis. Since I show that inactivation of APC-Cdh1 is required
for CLB2pr activation (see chapter 3.8), I speculate that the entire regulatory set
of events leading from Start to APC-Cdh1 inactivation to induction of CLB2
expression might be invariable in timing. Directly measuring the time between
APC-Cdh1 inactivation and CLB2pr activation in the same cell would reveal if
this timing interval is invariable. If this interval is indeed found to be constant,
this would suggest a deterministic chain of events leading from Start to APC-
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Cdh1 inactivation to CLB2 expression, which leaves entire post-Start variability
to be generated by events after CLB2pr induction.

A general future direction is further dissection of the variability of cell cycle
events after CLB2pr activation. I propose measurement of timing of a further set
of cell cycle events, such as markers for transcriptional activity of genes that
regulate the S-phase, chromosome segregation, and mitotic exit, both with
respect to budding and cytokinesis, as well as with respect to each other. Using
multiple transcriptional markers in the same cell should be possible by
combining spectrally non-overlapping fluorescent proteins. Taken together,
these measurements should be able to narrow down and define intervals that
generate the observed variability, as well as provide a basis for further studies
into mechanisms that generate and/or suppress variability in the budding yeast
cell cycle.
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Chapter 3: Analysis of multisite phosphorylation of Cdh1

In this chapter, I investigate the mechanism of APC-Cdh1 inactivation by
multisite phosphorylation. There are 11 putative CDK phosphorylation sites on
the Cdh1 protein (figure 3.1; Zachariae et al 1998, Robbins & Cross 2010a). In
complete absence of CDK phosphorylation, Cdh1 remains associated with the
APC and active (Zachariae et al, 1998). Exact gene replacement of the CDH1
gene with an allele lacking all 11 phosphorylation sites, CDH1-m11, at the
endogenous locus, confirmed that unregulated CDH1-m11 is incompatible with
viability due to the inability to restrain the APC-Cdh1 activity at the entry into
mitosis (Robbins and Cross, 2010a). Cells bearing the unphosphorylatable
CDH1-m11 allele entered the S-phase and underwent one round of DNA
replication normally, but failed to depolarize bud growth and form mitotic
spindles. These defects were found to be due to unrestrained Clb2 proteolysis
(Robbins and Cross, 2010a).

A correlation between the number of CDK phosphorylation sites on Cdh1 and
the ability to suppress degradation of mitotic cyclins has previously been
reported (Zachariae et al, 1998). However, the study relied on overexpression of
Cdh1, which is problematic because even overexpression of wild type CDH1
from GAL1 promoter is almost lethal (Martinez et al, 2006). Furthermore, the
survey did not directly address the importance of particular phosphorylation
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sites. Here, I assessed the need for particular phosphorylation sites, in the
context of endogenous expression levels, and elucidate the relationship
between the number of phosphorylation sites, APC-Cdh1 activity, and the
phenotype at the cellular level.

3.1. No single CDK phosphorylation site on Cdh1 is essential for viability

In order to assess the requirement for particular phosphorylation sites in the
context of endogenous expression levels, Jonathan Robbins constructed a
series of partially phosphorylatable CDH1 alleles (J. Robbins, PhD thesis).
Serine of threonine residues in the CDK consensus motif were mutated to
alanine, starting either with the most N-terminal or C-terminal site and mutating
consecutive sites (J. Robbins, PhD thesis).

In the series of mutants where sites were mutated from the C terminus, mutation
of up to eight phosphorylation sites caused no loss of viability (figure 3.1, blue
line on the diagram). In contrast, mutants in N-terminal sites were more
sensitive; while 7 C-terminal sites were sufficient for complete viability, the
mutant allele bearing only 4 C-terminal phosphorylation sites was lethal (figure
3.1, green line on the diagram).
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T12 S16 S42

S169 T176 S239
T157 T173 S227

S418 S436

Cdh1

Figure 3.1: A scheme of Cdh1 with CDK consensus sites (S/T followed by a P
residue). The sites are referred by their sequential number, counting from the
most N-terminal site. The blue and green lines on the bottom indicate the
minimal number of phosphorylation sites required for N-terminal and Cterminal sites, respectively (see text). These results are summarized from J.
Robbins, PhD thesis.
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Cell viability is therefore not dependent on any particular phosphorylation site,
since alleles compatible with viability were constructed with two non-overlapping
sets of phosphorylation sites; however, fewer sites are sufficient for viability on
the N-terminal side, suggesting that N-terminal sites are have stronger effects
on Cdh1 inhibition.

3.2. No single CDK phosphorylation site on Cdh1 is sufficient for viability

Follow up on this result, I asked whether any particular phosphorylation site
might alone be sufficient for viability. Since only three most N-terminal
phosphorylation sites were sufficient for viability, I reasoned that these sites
might contribute the most, and are therefore the most likely candidates for
phosphorylation sites sufficient for viability. Since overexpression of the inhibitor
Acm1 from a galactose-inducible promoter (GAL-ACM1) was previously shown
to allow for normal growth of CDH1-m11 cells, these CDH1 phosphomutants
were constructed in GAL-ACM1 background. Cells were then plated on glucose
(GAL-ACM1 off) to assess their viability.

Here, I will refer to the phosphorylation sites by the sequential number of the site
from the N-terminus, and refer to the mutants by the phosphorylation sites that
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are present (for instance, Cdh1-3P contains only the third phosphorylation site,
but lacks the remaining sites).

I constructed partially phosphorylatable CDH1 mutants bearing only the first,
second or third phosphorylation site, as exact gene replacements to ensure
endogenous expression levels. Upon plating onto glucose, none of these single
phosphorylatable CDH1 alleles allowed cell viability, since cells were not able to
form colonies up on glucose (figure 3.2).

In addition, I constructed partially phosphorylatable alleles bearing combinations
of two among the three N-terminal phosphorylation sites. I found that cells
bearing the CDH1-2,3P allele (with the second and third sites present) were
partially viable on glucose; however, compared to colony formation on
galactose, colony formation was reduced by a factor of 10 to 100.

I conclude that among the phosphorylation sites in the N-terminal part, no single
site was sufficient for viability, and that at least two phosphorylation sites are
required for (partial) viability. Since I did not test the remaining 8 sites for
sufficiency for viability, I cannot formally exclude that one of these sites might be
alone sufficient for viability; however, this conclusion is justified by the fact that
C-terminal sites appear weaker than the C-terminal sites in the ability to inhibit
Cdh1.
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CDH1-m11
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CDH1-1,3P
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CDH1

G

D

Figure 3.2: No single phosphorylation site is sufficient for viability. Tenfold
dilutions of strains bearing CDH1 alleles with only one or two phosphorylation
sites. D, glucose; G, galactose.
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CDH1-5:11P

CDH1-2,3P

CDH1-m11

CDH1

Figure 3.3: DIC images of cells bearing partially phosphorylatable CDH1
alleles. Images were taken with 63x objective.
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3.3. Cells with partially phosphorylatable CDH1 alleles exhibit stochastic
morphological abnormalities

To assess the phenotype of cells bearing partially phosphorylatable CDH1
alleles, I took DIC images of cells in liquid cultures in glucose media. Cells
bearing the unphosphorylatable CDH1-m11 allele exhibited uniformly abnormal
morphology (figure 3.3). These cells formed extremely elongated buds, owing to
the inability to depolarize bud growth due to lack of mitotic Clb-CDK activity (Lew
and Reed, 1993), and frequently rebudded multiple times (Robbins & Cross,
2010a).

In cultures of CDH1-2,3P cells, the long-budded or multiple budded cells
represented the majority; however, a small fraction of normally budded cells
were also observed. Other partially phosphorylatable CDH1 mutants also
showed sporadic morphologically defective cell cycles (Jonathan Robbins, PhD
thesis). In particular, cells bearing CDH1-5:11P (originally named CDH1-4N; in
this work the mutant is renamed for consistency with the naming used here),
which lacks the 4 N-terminal sites, but has the remaining 7 C-terminal sites,
were occasionally also long-budded, but the fraction of these morphologically
abnormal cells was smaller than CDH1-2,3P cells.
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3.4. Partially penetrant phenotype of CDH1-2,3P

To further characterize the phenotype in these cells lacking full phosphorylation
control, I performed fluorescent time-lapse microscopy using strains with a bud
neck marker, Myo1-mCherry, and the APC-Cdh1 biosensor (see chapter 2). In
particular, I focused on the CDH1-2,3P mutant, which showed variability in cell
morphology. The nuclear localization of the biosensor allowed me to monitor
nuclear morphology and assess nuclear division. The cells were grown in a
microfluidic chamber where I was able to rapidly switch media and induce or
repress gene expression (see materials and methods). First, the cells were
grown in galactose (GAL-ACM1 on) to form a small microcolony of ~10 cells,
and then switched to glucose to expose the phenotype of the CDH1 allele. Acm1
is very rapidly degraded during mitotic exit and in G1 phase, and is stabilized by
phosphorylation from budding to mitosis (Enquist-Newman et al, 2008).
Therefore, the cells that have budded by the time a switch to glucose occurred
were be protected until the next G1, but enter the next cell cycle with no leftover
Acm1, as the depletion of GAL-ACM1 has been shown to be very effective
(Robbins and Cross, 2010a). I therefore count the first cell cycle in the
experiment as the first cycle that the cell initiated as an unbudded cell in
glucose.
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Figure 3.4: CDH1-2,3P mutant exhibits a partially penetrant cell cycle
phenotype. A) Fraction of cells that completed the first cell cycle (starting as
an unbudded cell in glucose). B) Fraction of cells that completed at least one
nuclear division during the time-lapse. Inset, a composite image of a CDH12,3P cell that formed elongated buds and also completed the nuclear division.
Red, Myo1-mCherry (bud neck marker); yellow, APC-Cdh1 biosensor (nuclear
marker). C) Images at representative intervals from a 20-hour time-lapse of
CDH1-2,3P cells illustrate partial penetrance in colony formation of CDH12,3P. Same fluorescent markers as in B.
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CDH1-m11 cells uniformly arrested in the first cell cycle upon switch to glucose
(figure 3.4). In accordance with previous results (Robbins and Cross, 2010a),
these cells established a new bud site and proceeded to grow elongated buds
without switching to isotropic bud growth, and never underwent cytokinesis
(Myo1-mCherry signal remained present at the bud site). During the duration of
the time lapse (7 hours), these cells often rebudded (i.e. established a new bud
site either on the cell body or on the bud) and formed multiple elongated buds.
The nuclei, marked by the localization of the biosensor, were stuck at the bud
site, and remained undivided in all observed cells throughout the duration of the
time-lapse (figure 3.4).

In contrast, CDH1-2,3P cells were variable. 20% of the cells (4/20) successfully
completed the first cell cycle after switch to glucose (figure 3.4 A). Other cells
formed elongated buds and rebudded, like CDH1-m11 cells, without completing
cytokinesis. I also observed variability in nuclear morphology in these cells.
Frequently, nuclei rapidly migrated along the nascent buds. In addition, 62%
(13/21) of arrested CDH1-2,3P cells performed at least one round of nuclear
division (figure 3.4 B). However, I note that these nuclear divisions were often
visibly aberrant – the nuclear mass separated unevenly, and the newborn nuclei
remained attached. Nuclear divisions also occurred at very variable times
throughout the arrest (shown on traces in figure 3.5), although due to
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morphological abnormalities the precise timing of nuclear divisions was often
impossible to score.

In summary, on the single cell level, CDH1-2,3P exhibited partially penetrant cell
cycle phenotype, as a fraction of cells were capable of progressing through the
cell cycle, and a fraction of cells arresting. While I label these cells “arrested”
because of their morphological abnormality and failure to perform an essential
cell cycle event (cytokinesis), these cells continued to perform other cell cycle
events such as nuclear division and establishment of bud sites, and as judged
by the growth on the colonies on the plates, at least some of these cells were
ultimately viable.

It was surprising that a big fraction of CDH1-2,3P cells resembled arrested
CDH1-m11 cells, but still a fraction of these cells managed to escape and form
colonies on glucose plates (figure 3.2). To investigate this phenomenon, I
performed longer time-lapse experiments. In these experiments, single cells
were plated in the microfluidic device, immediately switched to glucose media,
and imaged for 20 hours. As described above, these cells grew elongated buds,
re-budded, and divided their nuclei within that period. Strikingly, however, at 10
an 15 hours time points, some of these long-budded multinucleated cells started
producing morphologically normal cells, and by the 20 hour time point, grew into
a sizeable colony of mostly morphologically normal cells (figure 3.4 C), which
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likely had the ability to form a macroscopic colony. This phenomenon was
observed in 30% of imaged cells, while the rest of the cells did not recover and
started to lyse by the end of the experiment.

However, in an attempt to investigate this phenomenon by recovering cells
grown on glucose plates, I noticed that these cells were no longer able to arrest
even transiently. I therefore conclude that the cells that switched to
morphologically normal cells likely suffered an irreversible genetic change.

3.5. Complex phenotype of CDH1-2,3P due to partially regulated APC-Cdh1
activity

The APC-Cdh1 biosensor in these cells allowed me to assess the dynamics of
APC-Cdh1 activity. CDH1-m11 cells arrested with low fluorescence levels,
suggesting persistently high APC-Cdh1 activity (figure 3.5 B). In contrast,
arrested CDH1-2,3P maintained intermediate biosensor levels between wild
type and CDH1-m11 cells (quantified as average biosensor fluorescence in the
mother cell body excluding the elongated bud, figure 3.5 B).

In addition, CDH1-2,3P cells exhibited dynamic biosensor levels in the arrest.
This dynamics can at least partially be explained by mean fluorescence of the
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cell dropping due to nuclear division as described in chapter 2.4. In addition,
many CDH1-2,3P cells exhibited aberrant nuclear migration along the elongated
buds. However, even in cells where the nucleus remained in the mother cell
body (not in the bud) throughout the imaging period, the oscillations occurred
without any nuclear division (figure 3.4 A). This implies APC-Cdh1 activity in
CDH1-2,3P cells undergoes oscillations in activity, presumably due to cycles of
phosphorylation and dephosphorylation of Cdh1-2,3P at the remaining two sites.
This dynamic behavior was irregular in both amplitude and timing, and the time
between peaks was generally longer than in wild type.

Overall, the results indicate that partial phosphorylation of Cdh1 allows for
partial, but not complete inactivation of APC-Cdh1. Comparison with CDH1-m11
reveals that Cdh1-2,3P allows for partial inactivation of APC-Cdh1, which
implies that the remaining two phosphorylation sites are phosphorylated at least
some of the time. However, due to dynamic activity of APC-Cdh1 in these
arrested cells, precise quantification of APC-Cdh1 activity, compared to wild
type APC-Cdh1 activity, was not possible.
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Figure 3.5: APC-Cdh1 activity in CDH1-2,3P cells. A) Representative time
courses of APC-Cdh1 biosensor fluorescence for two CDH1-2,3P cells (solid
lines), along with wild type and CDH1-m11 cells (dashed lines). B)
Quantification of average biosensor fluorescence intensities. Error bars
represent standard deviation. Fluorescence intensities were corrected for
autofluorescence by subtracting fluorescence intensities of unlabeled cells.
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3.6. CDH1-2,3P cells arrest with dynamic Clb2 levels

I assessed whether partial phosphorylation of Cdh1 allows for accumulation of
mitotic cyclin Clb2. CDH1-m11 cells did not have any detectable Clb2 levels by
western blot (figure 3.7), consistent with previous results (Robbins and Cross,
2010a). However, Clb2 was detected in CDH1-2,3P cells, although the level was
lower than asynchronous wild type cells (figure 3.7).

To assess the Clb2 levels in CDH1-2,3P cells on the single cell level, I
performed time-lapse microscopy using GFP-tagged endogenously expressed
CLB2 (Lu and Cross, 2010). In CDH1-m11 cells, no detectable Clb2-GFP signal
was observed. In contrast, in CDH1-2,3P cells, detectable Clb2-GFP
accumulation was observed. Clb2-GFP levels were dynamic, and ranging from
zero to approximately peak levels of wild type cells. Qualitatively, these traces
were similar to APC-Cdh1 biosensor in CDH1-2,3P cells, with no regular pattern
of oscillations.
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Figure 3.6: Clb2 levels in CDH1-2,3P cells. A) representative time courses of
Clb2-GFP fluorescence in two CDH1-2,3P cells (solid lines), along with wild
type and CDH1-m11 cells (dashed lines). Fluorescence intensities were
corrected for autofluorescence by subtracting fluorescence intensities of
unlabeled cells. B) Immunoblots against Clb2 at 6 hours after switch to
glucose (GAL-ACM1 off).
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3.7. Restoring Clb2 levels by introducing a partially degradation-immune
CLB2 allele does not rescue the cell cycle phenotype of CDH1-2,3P

Next, I wanted to test whether the levels of mitotic cyclin accumulated in CDH12,3P cells are sufficient for cell cycle progression (implying that other APC-Cdh1
targets are the limiting factor), or whether the cell cycle arrest occurs due to
insufficient Clb2 levels. To do that, I introduced CLB2-ken, a partially nondegradable version of Clb2 expressed from the endogenous CLB2 promoter
instead of wild type CLB2, into CDH1-2,3P cells. Previously, it was found that
the defects in entering into mitosis in CDH1-m11 cells were due to inability to
establish mitotic Clb-CDK activity, as introducing a completely non-degradable
CLB2-kd allele into CDH1-m11 cells restored the depolarization of bud growth,
and allowed for formation of mitotic spindle (Robbins and Cross, 2010a).

Clb2-ken is partially immune to degradation by APC; mutation of KEN boxes
prevents degradation by APC-Cdh1, but not APC-Cdc20 (Wasch and Cross,
2002). I used only a partially degradation immune CLB2-ken with an expectation
that I might be able to observe a complete rescue of cell progression; while
using CLB2-kd restores even higher Clb2 accumulation, it does not allow for
mitotic exit and results in arrest, which would make the interpretation of the
result more difficult.
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Figure 3.7: Restoring Clb2 levels does not rescue the phenotype associated
with incomplete APC-Cdh1 inactivation. A) Immunoblots against Clb2 (top).
Relative intensities of Clb2/Pgk1 signal, normalized to the wild type ratio
(bottom). B) Representative time courses of the APC-Cdh1 biosensor
fluorescence in two CDH1-2,3P CLB2-ken double mutant cells (solid lines)
along with a wild type cell (dashed line). Fluorescence intensities were
corrected for autofluorescence by subtracting fluorescence intensity of
unlabeled cells.
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CLB2-ken cells are viable and largely morphologically normal, but they contain
approximately twice the amount of wild type Clb2 levels in asynchronous
population (figure 3.7 A). Introducing CLB2-ken into CDH1-2,3P cells restored
average Clb2 levels, measured by western blot, to about wild-type levels, but not
to the levels of CLB2-ken cells (figure 3.7 B). This indicates that perhaps Clb2ken can still be degraded by APC-Cdh1-2,3P, or that Clb2-ken degradation by
APC-Cdc20 is higher in CDH1-2,3P CLB2-ken cells than in CLB2-ken cells
(Clb2-ken is immune only to degradation by APC-Cdh1 and not to degradation
of APC-Cdc20).

However, despite elevated Clb2 levels in these cells compared to CDH1-2,3P
cells, the morphology and cell cycle progression phenotype of these cells
remained similar to CDH1-2,3P cells. Time lapse microscopy of CDH1-2,3P
CLB2-ken cells revealed no detectable difference from CDH1-2,3P cells. CDH12,3P CLB2-ken cells also displayed a variability in cell cycle progression, with a
fraction of cells completing the first cell cycle after GAL-ACM1 off switch (2/18
cells, compared to 4/20 for CDH1-2,3P cells). Occasional nuclear divisions in
CDH1-2,3P CLB2-ken cells were also observed (8/20, compared to 13/21 for
CDH1-2,3P cells). In arrested cells, the averaged levels of the APC-Cdh1
biosensor were similar to CDH1-2,3P cells, and the behavior of the biosensor
was similarly dynamic (figure 3.7).
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Overall, introducing partially non-degradable Clb2 into CDH1-2,3P cells did not
rescue the phenotypes associated with the CDH1-2,3P mutant. Therefore, Clb2
is might not be the limiting target of APC-Cdh1-2,3P degradation in depolarizing
bud growth and progression through the cell cycle. This contrasts with previous
result, where rescue of the depolarized bud growth was achieved by introducing
a completely non-degradable Clb2-kd into completely unregulatable CDH1-m11
cells. A likely possibility is that Clb2-ken into cells does not cause establishment
of Clb2-CDK activity with proper timing, even though the overall Clb2 levels are
elevated. Using a GFP-tagged version of CLB2-ken in CDH1-2,3P cells would
allow to directly assess the dynamics of Clb2-ken accumulation.

3.8. Periodic gene expression in CDH1 phosphomutants

Periodic gene expression is associated with the cell cycle; in each cell cycle, a
significant fraction of the genome undergoes once per cell cycle activation of
expression (Spellman et al, 1998). However, the relationship between cell cycle
regulators and periodic gene expression is not fully understood, and it remains
unresolved whether, and to what extent, these changes in gene expression are
regulated by cyclin-CDK activity and whether periodic gene expression is
sustained in arrested cells at various cell cycle stages (Orlando et al, 2008;
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Simmons-Kovacs et al, 2011; Bristow et al, 2014; see also chapter 5). Here, I
wanted to assess whether lack of inhibition of APC-Cdh1 still allows for
expression of cell cycle-regulated genes.

To address these questions, I measured expression of three genes, associated
with the three main gene expression regulons in the yeast cell cycle, in CDH1m11 and CDH1-2,3P cells. This was done using constructs where a fluorescent
protein was placed under the control of the gene promoter. CLN2 is a
representative of the regulon associated with the transcription at the G1/S phase
border; it is regulated by transcriptional factors SBF and MBF. CLB2 promoter is
a representative of the G2/M regulon, and its transcription is regulated by a
complex containing Mcm1, Fkh1/Fkh2 and Ndd1 (Koranda et al, 2000). SIC1
promoter is a representative of the regulon expressed at the exit of mitosis
(G2/M border), which is regulated by transcription factors Swi5 and Ace1 (see
introduction).

CLN2 promoter was turned on in both CDH1-m11 and CDH1-2,3P cells (figure
3.8); the CLN2pr-GFP signal was similar to wild type cells and possibly periodic,
although the oscillations were not as regular as in wild type cells. This was
expected, given the fact that CLN2 is expressed before APC-Cdh1 inactivation
and APC-Cdh1 inactivation does not have a role in preventing the transcription
of G1/S genes. It is also consistent with the observations of elongated bud
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morphology and periodic rebudding in CDH1-2,3P and CDH1-m11 cells, since
Cln-CDK is the driver of polarized bud growth and rebudding (Lew and Reed,
1993).

CLB2 promoter was not activated in CDH1-m11 cells (figure 3.8). This is in
agreement with the proposed positive feedback model for mitotic cyclin
expression, in which Clb2-CDK activity is required for full induction of CLB2
expression (Amon et al, 1993). This establishes that inactivation of APC-Cdh1 is
essential not only for accumulation of Clb2 protein, but also for activation of
CLB2 expression (see chapter 2).

In contrast, CLB2 promoter was activated in CDH1-2,3P cells. The CLB2pr-GFP
signal was as high as in wild type cell peaks, with no regular periodic activity,
implying that CLB2 promoter might be permanently turned on, although I note
that due to very low dynamic range of CLB2pr-GFP, low signal to noise ratio
makes it challenging to establish whether the dynamics is due to periodic
activation or merely due to noise.

Similar results were observed for SIC1 promoter; CDH1-m11 cells did not
activate SIC1 transcription, while CDH1-2,3P cells turned on expression of SIC1
promoter (figure 3.8).
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Figure 3.8: Cell cycle-associated transcription in CDH1 phosphomutants.
Upper left, expression of CLN2pr-GFP. Upper right, expression of CLB2prGFP. Bottom, expression of SIC1pr-YFP. Fluorescence intensities were
corrected for autofluorescence by subtracting fluorescence intensities of
unlabeled cells.
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In conclusion, APC-Cdh1 inactivation is required for activation of cell cycleregulated promoters. This set of experiments is relevant for the work presented
in chapter 5, where I, in collaboration with S. Jamal Rahi and Kresti Pecani,
analyzed cell cycle-regulated gene expression in absence of B-type cyclins.
Since unrestrained activity of APC-Cdh1 prevents accumulation of mitotic
cyclins, this experiment is similar, although not exactly equivalent, to the
experiment performed in chapter 5, where all B-type cyclins CLB1-6 were
genetically deleted. The differences are that Clb5 and 6 are present in CDH1m11 cells (and not in clb1-6 cells), but APC-Cdh1-m11 also does not allow for
accumulation of other APC-Cdh1 targets that might in principle be present in
clb1-6 cells. Generally, later cell cycle genes are largely not expressed in cells
deleted for B-type cyclins (see chapter 5), although SIC1 was found to be a
notable exception of a gene that is expressed in clb deleted cells (Rahi et al,
submitted). Lack of expression of SIC1 in CDH1-m11 cells suggests that B-type
cyclin-CDK-independent mechanism of SIC1 expression is dependent on one
(or more) of the APC-Cdh1 targets; or that presence of Clb5 and 6 (or perhaps
residual Clb1-4 not fully degraded by APC-Cdh1-m11) inhibits SIC1 expression.
Global transcriptome profiling in CDH1-m11 cells would provide an insight into a
complete picture of gene expression and, in comparison to the data from cln-clbcells (Chapter 5) reveal if inactivation of APC-Cdh1 is required for the periodic
gene expression.
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However, in partially phosphorylatable CDH1-2,3P cells, I found that expression
of cell cycle-regulated genes (at least for the representatives of the two
regulons) was allowed. This suggests that partial restrainment of APC-Cdh1
activity, while not sufficient for cell cycle progression (these cells were arrested
as long-budded cells), was sufficient for continuation of the cell cycle
transcriptional program.

3.9. Conclusions and future directions

In this study, I followed up on previous work addressing multisite
phosphorylation of Cdh1. Previous studies have partially addressed this
question; Zachariae et al found that the association with the core APC depends
gradually on the number of phosphorylation sites on Cdh1 (Zachariae et al,
1998). Previous data also showed that no single site on Cdh1 is necessary for
viability, but that some sites contribute more to the inhibition, as concluded from
the number of sites required. (J. Robbins, PhD thesis). Here, I expanded these
findings by defining a minimal set of phosphorylation sites required, and an indepth analysis of the phenotype associated with partial removal of
phosphorylation sites.
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First, I tested whether one single site might be sufficient for viability. Of the three
more likely candidates among the N-terminal sites, no single site mutant was
viable. Therefore, no single site is sufficient for required inactivation of APCCdh1. However, it is formally possible, although unlikely, that any of the weaker
C-terminal sites might be sufficient for viability. Overall, this screen for partially
phosphorylatable CDH1 mutants has an implication for the mechanism of Cdh1
phosphorylation, which could be addressed by carrying out biochemical
experiments.

An important observation is that the failure of sufficient inactivation of APC-Cdh1
in these mutants is stochastic, not deterministic. Rather that a uniform response
of in the entire population of cells, two partially phosphorylatable mutants were
found (CDH1-2,3P and CDH1-5:11P) that exhibit variability in cell morphology.
The frequency of morphologically normal and arrested cells was different in
those two mutants, implying that degree of APC-Cdh1 inactivation might
modulate the probability of successful cell cycle progression. On the single cell
level, time-lapse microscopy of CDH1-2,3P cells showed that while the majority
of the cells were unable to progress through the cell cycle, a small fraction of
cells completed the cell cycle.

The phenomenon, in which genetically identical cells exhibit variability in
phenotype, is called partial penetrance. Partial penetrance has been observed
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and characterized in many biological systems, including sporulation in Bacillus
subtilis (Eldar et al, 2009) and vulval development in Caenorhabditis elegans
(Milloz et al, 2008), but it has not been well studied in budding yeast cell cycle,
although mutants that cause stochastic cell cycle arrest have been identified (for
instance, stochastic G1 arrest in cln1,2 cells (Skotheim et al, 2008)). It is
generally believed that partial penetrance in genetically identical cells is caused
by molecular noise.

Interestingly, CDH1-2,3P also exhibited partial penetrance in long-term growth
and colony formation. Consistent with partial ability to form colonies on agar
plates, time lapse imaging of single CDH1-2,3P cells revealed that even though
all cells initially become long-budded, resembling a CDH1-m11-like arrest, a
fraction of cells escaped arrest and gave rise to normally dividing progeny.

Using the quantitative essay for APC-Cdh1 activity in partially phosphorylatable
CDH1 mutants, I aimed to further characterize the stochastic cell fate in CDH12,3P cells. For instance, by correlating cell cycle progression with APC-Cdh1
activity in single cells, one might be able to discriminate whether the variability is
caused upstream or downstream of Cdh1 inactivation; if the degree of APCCdh1 inactivation as measured by biosensor correlates with probability of cell
cycle completion, the cause is likely in upstream regulators, whereas if APCCdh1 is inactivated to a (on average) uniform level in both arrested and
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unarrested cells, one might conclude that probability of cell cycle progression is
determined by the molecular noise downstream of Cdh1 phosphorylation.

However, this experiment was hindered by the technical limitations of the
biosensor. Quantification of APC-Cdh1 activity in single CDH1-2,3P cells was
impossible because of dynamic behavior of the system. By comparison to
CDH1-m11 cells, an indisputable conclusion is that APC-Cdh1-2,3P is partially
inactivated, which implies that Cdh1-2,3P is phosphorylated at the remaining
two sites at least some of the time; however, I cannot make further quantitative
statements about APC-Cdh1 activity.

To improve this assay, one would need to devise an experimental system where
partially phosphorylatable Cdh1-2,3P would be “locked” in a phosphorylated
state and eliminate APC-Cdh1-independent degradation of the biosensor. Since
Cdc14 is responsible for dephosphorylation of Cdh1, the assay would require
deleting CDC14 to maintain the phosphorylation state of Cdh1-2,3P. This would
presumably lock the cells with partial APC-Cdh1 activity corresponding to fully
phosphorylated Cdh1-2,3P; however, this experimental setup would have other
limitations. Because CDC14 is essential for mitotic exit, deletion of CDC14
would by itself interfere with cell cycle progression. The experiment could in
principle be done with a temperature-sensitive cdc14 allele.

73

Partial penetrance observed in CDH1-2,3P is in dramatic contrast with the
stereotyped inactivation of APC-Cdh1 with highly regular timing in wild type cells
(chapter 2). This highly regular timing in wild type suggests an evolved
mechanism for noise buffering and minimizing variability. Partial removal of a
subset of phosphorylation sites greatly increased cell-to-cell variability. However,
this variability is not in timing of APC-Cdh1 inactivation, but rather, depending on
the two possibilities above, the degree of APC-Cdh1 inactivation, or the degree
by which partially inactivated APC-Cdh1 can allow for cell cycle progression.

It therefore remains unresolved how the partially penetrant phenotypes in cells
with partially phosphorylatable CDH1 arise. To gain understanding of these
phenotypes, I asked how multiple regulatory mechanisms contribute to APCCdh1 inactivation and interact with each other in the next chapter.
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Chapter 4: Exploring the interactions between APC-Cdh1 regulators

Multiple negative regulators of APC-Cdh1 inactivation exist (see introduction).
While preventing binding of Cdh1 to the APC core by means of inhibitory
phosphorylation of Cdh1 by CDK is the most important mechanism (Zachariae
et al, 1998), there are other additional mechanisms. APC-Cdh1 is inhibited by a
pseudosubstrate inhibitor Acm1 (Martinez et at, 2006), and Cdh1 is also
regulated by nuclear export, mediated by a karyopherin Msn5 (Jaquenoud et al,
2002). Furthermore, multiple cyclins, associated with CDK, can potentially have
a role in Cdh1 phosphorylation. Initial work has suggested G1 cyclins to be
essential for Cdh1 inactivation (Amon et al, 1993), but subsequent work has
implied direct roles of Clb3,4 and 5 (Yeong et al, 2001), and Clb5,6 (Huang et al,
2001), in regulation of Cdh1. In this chapter, I explore the contribution of and the
interplay between these multiple redundant regulatory mechanisms.

In addition to CDK, Cdh1 was found to be phosphorylated at multiple other sites
by additional kinases (Hall et al, 2006), although significance of this
phosphorylation is not understood. In particular, phosphorylation of Cdh1 by the
polo kinase Cdc5 was suggested to contribute to APC-Cdh1 inactivation (Crasta
et al, 2008), although conclusions of those results were later disputed (Robbins

75

and Cross, 2010a). I do not address phosphorylation of Cdh1 by other kinases
in this work.

4.1. Deletion of CLB5 and 6 delays APC-Cdh1 inactivation

To assess the contribution of the S-phase cyclins to APC-Cdh1 inactivation, I
performed time lapse experiments and measured the time of inactivation of
APC-Cdh1 in clb5,6 cells with respect to budding, using the APC-Cdh1
biosensor as described in chapter 2. I performed the described data analysis
procedure to remove unreliable data points (chapter 2.5). I find that deletion of
CLB5 and 6 still allows for reliable APC-Cdh1 inactivation, as there were no
morphological defects observed in clb5,6 cells, and biosensor levels oscillated
during the experiment. However, the apparent inactivation of APC-Cdh1 is
delayed on average by 6 minutes with respect to wild type cells (measured with
respect to budding; figure 4.1). While the difference is not big, it is statistically
significant (Mann-Whitney p=2.8*10-4), and probably biologically meaningful,
since many cell cycle events occur on in short time in budding yeast. A delay of
the same Ase1 degron fragment degradation has previously been observed
qualitatively in bulk cultures (Huang et al, 2001).
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Figure 4.1: Timing of inactivation of APC-Cdh1 in clb5,6 cells, measured by
time-lapse microscopy with APC-Cdh1 biosensor.
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This suggests that Clb5 and 6-CDK are probably the physiological kinases
responsible for inactivating APC-Cdh1. However, clearly, other cyclin-CDKs
and/or other regulators are capable of carrying out sufficient APC-Cdh1
inactivation, either later in the cell cycle, or with reduced efficiency.

4.2. Partially phosphorylatable CDH1-2,3P allele shows negative genetic
interactions with clb5 and acm1

Next, I looked for genetic interactions of deletions of APC-Cdh1 regulators with
the partially phosphorylatable CDH1 mutant, CDH1-2,3P. CDH1-2,3P cells are
viable, but have a reduced ability to form colonies, and exhibit stochastic
morphological phenotypes associated with incomplete inactivation of APC-Cdh1
(chapter 3). Again, the strains were constructed in GAL-ACM1 background.

First, I tested interactions with ACM1 and MSN5 deletions. The logic of this
experiment was that inhibition by Acm1 or nuclear export (via Msn5) might
become essential if activity of APC-Cdh1 is not sufficiently restrained by Cdh1
phosphorylation. Furthermore, nuclear export by Msn5 might depend specifically
on phosphorylation at particular sites on Cdh1.
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Figure 4.2: Genetic interactions with CDH1-2,3P. Top, genetic interactions
with acm1 and msn5. Bottom, genetic interactions with clb5 and clb6. Strains
were constructed in GAL-ACM1 background. Tenfold serial dilutions were
plated. G, galactose; D, glucose.
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Deletion of MSN5 and ACM1 had no effects on viability and colony formation in
wild-type CDH1 cells (J. Robbins, PhD thesis; data not shown). CDH1-2,3P
showed no genetic interaction with msn5 on the level of colony formation.
However, CDH1-2,3P was lethal in combination with deletion of ACM1 (figure
4.2). This indicates that endogenous levels of Acm1 contribute to inhibition of
APC-Cdh1, and that this inhibition becomes essential when APC-Cdh1 activity is
not sufficiently restrained by phosphorylation.

For MSN5, genetic interactions with other partially phosphorylatable alleles have
been tested before, and no genetic interactions on the level of colony formation
were found with any of the tested partially phosphorylatable CDH1 mutants (J.
Robbins, PhD thesis). Nuclear export mediated by Msn5 requires Cdh1
phosphorylation (Jaquenoud et al, 2002). The interpretation of this result can be
that Msn5 does not physically interact with any particular phosphorylation site,
such that nuclear export of Cdh1 can occur if regardless of the particular
phosphorylation site. An alternative explanation is that the nuclear export has a
minor contribution to APC-Cdh1 inactivation, and its elimination does not have a
noticeable effect, at least on the level of colony formation.

Next, I tested genetic interactions of CDH1-2,3P with deletions of CLB5 and 6,
which were found to likely be the main physiological kinase for Cdh1
phosphorylation (chapter 4.1). The idea behind this experiment was that if the
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remaining Cdh1 sites are phosphorylated exclusively by Clb5 and/or Clb6-CDK,
deletion of CLB5 and/or 6 would phenocopy the completely unphosphorylatable
CDH1-m11 allele and result in loss of viability.

clb5,6 cells are fully viable and have no defects in colony formation (data not
shown). I found that deletion of CLB5 in CDH1-2,3P background resulted in loss
of viability (figure 4.2). Deletion of CLB6 did not have any effects, presumably
because Clb6-CDK contributes significantly less to the total S-phase cyclin-CDK
activity. This is probably due to the fact that it is about 10x less abundant than
Clb5 (Cross et al, 2002), and generally deletion of CLB6 has no phenotype if
CLB5 is present.

Similarly, deletion of CLB5 also resulted in lethality in combination with the
CDH1:5:11P mutant lacking the N-terminal phosphorylation sites (J. Robbins,
PhD thesis). This result shows that when phosphorylation control is partially lost
by removing either the N-terminal or the C-terminal sites, other cyclin-CDKs that
are otherwise capable of compensating for loss of Clb5-CDK, are not sufficient
for Cdh1 phosphorylation; however, alternative interpretations, involving indirect
effects of Clb5-CDK phosphorylation of other targets, are possible. Because
CDK phosphorylation causes stabilization of Acm1 (Melesse et al, 2014), it is
possible that deletion of CLB5 in partially phosphorlatable CDH1 mutants
causes lethality due to failure of Acm1 stabilization. If this interpretation is
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correct, mutating phosphorylation sites on Acm1 would phenocopy loss of CLB5
in partially phosphorylatable CDH1 mutants.

4.3. Simultaneous deletion of ACM1, CLB5 and CLB6 causes stochastic
morphological defects

Based on the results that Clb5-CDK is likely the physiological kinase responsible
for Cdh1 phosphorylation, and that Acm1 becomes important if phosphorylation
of Cdh1 is impaired, we reasoned that simultaneous loss of CLB5, CLB6 and
ACM1 might by itself have deleterious consequences even in presence of all the
phosphorylation sites on Cdh1.

The triple mutant cells were constructed in the GAL-ACM1 background and then
plated onto glucose media to assess their viability. Cells with the triple deletion
of clb5,6 acm1 were viable and able to form colonies on glucose (data not
shown). However, a small fraction of these cells (10%) exhibited a
morphological abnormality. Morphologically abnormal cells were not observed in
either acm1 or clb5,6 cells. These cells had abnormally elongated buds. This
phenotype was seen before in partially phosphorylatable mutants (chapter 3)
and resembles the long-budded morphology of CDH1-m11 cells. Hyperpolarized
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Figure 4.3: Stochastic morphological defects in acm1 clb5,6 cells. Fraction of
morphologically abnormal long budded cells.
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growth is an indicator of lack of mitotic cyclin-CDK activity; mitotic cyclin-CDKs
are required for the switch to isotropic bud growth (Lew and Reed, 1993).
Therefore, presence of hyperpolarized buds in these cells could be an indicator
of stochastic defects in APC-Cdh1 inactivation, similar as observed in partially
phosphorylatable CDH1 mutants (chapter 3). This interpretation is plausible
because ACM1 has so far not been found to have any other role than inhibition
of APC-Cdh1; although other interpretations involving direct effects on mitotic
cyclins of downstream targets that regulate the bud growth switch are also
possible.

4.4. Deletion of G1 cyclins alleviates the stochastic defects in partially
phosphorylatable CDH1 mutants

Initially, G1 cyclins were implicated in APC-Cdh1 inactivation (Amon et al, 1993),
although it was later suggested that they are not sufficient (Yeong et al, 2001).
To clarify this, I examined genetic interactions between partially
phosphorylatable CDH1 alleles and deletions of CLN1 and 2. The logic behind
this experiment was the same as the CLB5,6 experiment; if Cln1 and 2-CDK
were uniquely required for phosphorylation of the remaining Cdh1 sites, deletion
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of CLN1 and 2 in that background would phenocopy unphosphorylatable CDH1m11 and cause lethality.

The strains were constructed in GAL-ACM1, as well as MET3-CLN2
background, in which CLN2 is conditionally expressed in absence of methionine
(but not expressed in + met) because deletion of CLN1 and 2 is severely
deleterious and results in frequent G1 arrest (Skotheim et al, 2008). The assays
were then carried out on media with added methionine.

Surprisingly, unlike CDH1-2,3P, the triple mutant CDH1-2,3P cln1,2 had no
reduced ability to form colonies. This is apparent from the image in figure 4.4 A;
however, to quantitatively assess the ability to form colonies, I plated bigger
volumes of cultures to count colony-forming units. The ability to form colonies in
the CDH1-2,3P mutant was decreased approximately tenfold (figure 4.4 B,
bottom left, compare G+met with D+met (MET3-CLN2 off in both cases)). In
comparison, the ability to form colonies was restored in CDH1-2,3P cln1,2 cells
(figure 4.4 B, bottom right, D+met), although the colony number was still slightly
reduced by approximately 40%. It can also be observed that turning on MET3CLN2 in CDH1-2,3P background, which causes moderate overexpression, as
well as a shift in timing of expression, of G1 cyclins, further reduces the colony
formation in CDH1-2,3P (figure 4.4 B, bottom left, D+met).
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In liquid culture, CDH1-2,3P cells exhibited hyperpolarized buds, indicating
failure in bud growth depolarization owing to only partial APC-Cdh1 inactivation,
as described before (chapter 3.3). However, the triple mutant CDH1-2,3P cln1,2
cells did not exhibit hyperpolarized but growth D+met (but were hyperpolarized
in D-met where MET3-CLN2 was on; figure 4.4 C). Therefore, the morphological
defects caused by insufficient APC-Cdh1 inhibition were completely restored by
deleting CLN1 and CLN2. I also note that CDH1-2,3P cln1,2 cells were, similarly
to cln1,2 cells, enlarged, owing to a well-studied prolonged growth period in G1
phase in absence of Cln1,2-CDK (Skotheim et al, 2008).

To assess the growth of these cells quantitatively, I performed time-lapse
microscopy of these cells. The strains contained Myo1-mCherry, the bud neck
marker, to measure the duration of the unbudded and budded periods of the cell
cycle. As noted above, deletion of CLN1 and CLN2 causes extended G1
(Skotheim et al, 2008); both cln1,2 cells, as well as CDH1-2,3P cln1,2 cells,
exhibited longer unbudded periods in both mothers and daughters compared to
wild type (data not shown).

As described in chapter 3.4, only 20% of CDH1-2,3P cells completed the first
cell cycle upon switching to glucose (and did so with a delay, compared to the
distribution budding to cytokinesis times for wild type; figure 4.4 D); the
remaining 80% of the cells were arrested as long-budded cells and did not
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Figure 4.4: Genetic interactions between partially phosphorylatable CDH1
mutants and deletion of CLN1,2. Abbreviations: D, glucose; G, galactose; Met,
methionine. Strains were constructed in GAL-ACM1 MET3-CLN2 background.
A) Tenfold serial dilutions of indicated strains. B) Counts of colony forming units
of indicated strains, normalized to number of colonies of each culture on G-met.
Error bars are standard error of the mean between plating triplicates. C)
Representative DIC images of cells with indicated genotypes in indicated media.
Images were taken 6 hours after switch from G-Met. D) Duration of the budded
period of the cell cycle measured by time lapse microscopy using Myo1mCherry as a bud neck marker in D+Met. D) Fraction of unbudded (u), budded
(b) and long budded (lb) cells of indicated genotype in D+Met.
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complete cytokinesis (Myo1-mCherry marker remained at the bud site
throughout). In contrast, 100% of CDH1-2,3P cln1,2 cells completed cytokinesis,
and did so with no delay in timing with respect to wild type or cln1,2 cells (figure
4.4 D). Therefore, deletion of cln1,2 in CDH1-2,3P background allows not only
for depolarizing bud growth, but also for reliable cell cycle progression until
cytokinesis.

Overall, no observed cell cycle defects in CDH1-2,3P cln1,2 cells are therefore
somewhat inconsistent with only partial inability to form colonies (figure 4.4 B). A
reduced ability to form colonies could be due to occasional G1 arrests due to
cln1,2 deletion; however, no colony formation defects is observed for cln1,2 cells
on D+met. The likely explanation for this discrepancy is a systematic plating
error in the experiment either for CDH1-2,3P cln1,2 cells or cln1,2 cells.

To test whether this rescue of partially phosphorylatable CDH1 mutants is
specific to the particular two phosphorylation sites present in the CDH1-2,3P
mutant, I looked for genetic interactions of another partially phosphorylatable
CDH1 mutation that causes stochastic failures in APC-Cdh1 inactivation with
cln1,2 deletion. As above, these strains were constructed in GAL-ACM1 MET3CLN2 background. On glucose + methionine, cells bearing the CDH1-5:11P
allele, which encodes Cdh1 protein that is missing the N-terminal 4 sites but
have the 7 C-terminal sites (J. Robbins, PhD thesis), arrested as long-budded
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cells with about 20% frequency (figure 4.4 E). However, these long budded cells
were completely absent in CDH1-5:11P cln1,2 strain (figure 4.4 E). I note that
both CDH1-2,3P cln1,2 and cln1,2 strains had a bigger fraction of unbudded
cells, owing to the prolonged G1 phase in absence of CLN1 and CLN2
(Skotheim et al, 2008).

In summary, deletion of G1 cyclins in strains bearing partially phosphorylatable
CDH1 alleles alleviates the phenotype of associated with incomplete APC-Cdh1
inactivation, and allows for both reliable bud growth depolarization, as well as
timely cell cycle progression throughout the rest of the cell cycle. This result was
unexpected and opposite to the prediction based on suggested role of Cln1,2CDK in inhibitory phosphorylation of Cdh1.

4.5. Deletion of CLN1,2 does not restore mitotic cyclin levels in partially
phosphorylatable CDH1 mutants

The morphological defects in cells bearing unphosphorylatable or partially
phosphorylatable alleles have been traced to the inability to accumulate mitotic
cyclins; mitotic cyclins are required for switching from polarized to depolarized
bud growth (Lew and Reed, 1993), and in their absence, abnormally elongated

90

buds are formed. Introducing non-degradable Clb2 into CDH1-m11 cells
restored the ability to depolarize bud growth (Robbins and Cross, 2010a)

Based on these predictions, I reasoned that deletion of CLN1 and 2 might,
through one of many potential pathways, allow for accumulation of higher levels
of mitotic cyclins in the CDH1-2,3P cells. To test that, I measured Clb2 levels by
immunoblotting in asynchronous cultures 6 hours after switching to glucose
media with methionine. As noted in chapter 3.6, CDH1-2,3P cells have reduced
but detectable Clb2 levels. cln1,2 cells have approximately wild-type levels of
Clb2. However, Clb2 levels in the triple mutant CDH1-2,3P cln1,2 are only
comparable to CDH1-2,3P cells and significantly lower than wild type Clb2
levels.

A possible explanation of this result is that deletion of CLN1 and 2 might allow
for depolarizing bud growth and cell cycle progression in CDH1-2,3P cells with
lower mitotic cyclin-CDK activity, by removing some yet unknown, Clb2-CDK
independent, pathway that inhibits bud growth depolarization; although
numerous other interpretations are possible. First, defects in CDH1-2,3P might
be due to improper timing, not overall levels, of Clb2 accumulation, and deletion
of CLN1 and 2 might advance Clb2 accumulation without elevating overall
levels. To test this, time-lapse experiments using a GFP-tagged Clb2 expressed
from the native promoter would be required.
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Figure 4.5: Western blotting for Clb2 levels in CDH1-2,3P cln1,2 cells.
Quantification was done by normalizing to Pgk1 intensity. Error bars represent
standard error of the mean from three biological replicates.
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Another possibility is that deletion of CLN1 and 2 might restore levels of other
mitotic cyclins Clb1,3 and 4, which are able to drive mitosis in absence of Clb2
(Richardson et al, 1992); western blotting for other mitotic Clbs would be
required to evaluate this possibility. Another possibility is that Clb2 levels do not
directly reflect Clb2-CDK kinase activity, since Clb2-CDK activity is also
controlled both by posttranslational modifications (Sia et al, 1996), as well as the
inhibitor Sic1 (Schwob et al, 1994). This could be addressed by kinase activity
assays of immunoprecipitated Clb2-CDK complexes.

4.6. Conclusions and further directions

Taken together, the data reveal redundancy in APC-Cdh1 inactivation and
suggest hierarchy among the negative regulators of APC-Cdh1. In addition to
phosphorylation sites on Cdh1, where redundancy exists in the number of
phosphorylation sites (chapter 3), I show here that multiple negative regulators
of Cdh1 contribute to APC-Cdh1 inactivation in a redundant manner.

Phosphorylation of Cdh1 by CDKs is essential and therefore certainly the most
important mode of regulation. However, phosphorylation of Cdh1 can be carried
out by multiple cyclin-CDKs. Here, I present two pieces of evidence that Clb5CDK, and its related partner Clb6-CDK, might be the main kinases responsible
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for phosphorylation of Cdh1. Firstly, CLB5 and 6 are required for timely
inactivation of APC-Cdh1; in absence of CLB5,6, inactivation of APC-Cdh1 is
delayed. However, clearly other, presumably later Clb-CDKs, are also capable
of carrying out sufficient Cdh1 phosphorylation for cell cycle progression.
Secondly, deletion of CLB5 is lethal in combination with partially
phosphorylatable CDH1 alleles lacking either the N-terminal (J. Robbins, PhD
thesis) or the C-terminal subset of sites. This argues that phosphorylation of
both of these subsets of sites might be carried out predominantly by Clb5-CDK,
although, as noted above, other interpretations involving requirement for
phosphorylation of other targets by Clb5-CDK, most plausibly Acm1, are
possible.

In contrast, we found no indication for inhibitory phosphorylation of Cdh1 by
Cln1 and 2-CDK. Direct measurement of timing of APC-Cdh1 inactivation in cells
deleted for CLN1 and 2 was impossible because of pleiotropic effects of Cln1
and 2; deletion of CLN1 and 2 also affect the timing of budding, sharpness of
Whi5 nuclear exit, as well as timing of expression of other Cdh1 regulators in the
G1/S regulon. However, in contrast to CLB5 and 6, deletion of CLN1 and 2 did
not genetically interact negatively with partially phosphorylatable CDH1 mutants,
but paradoxically completely rescued the phenotypes associated with lack of
Cdh1 phosphorylation sites. These results do not, however, conclusively prove
that Cln1 and 2-CDK do not have a role in Cdh1 phosphorylation.
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I currently do not have a plausible explanation for this unexpected result. A
possible explanation would be that Cln1,2-CDK phosphorylates Cdh1 at specific
sites in an activatory manner, and loss of this activatory phosphorylation by
deletion of CLN1 and 2 balances out the loss of inhibitory phosphorylation by
other kinases; however, since the same genetic interaction was observed with
two partially phosphorylatable alleles with non-overlapping subsets of sites, this
explanation can be ruled out. Further experiments can be done by time-lapse
microscopy using the APC-Cdh1 biosensor; this might reveal whether APCCdh1 is inactivated more completely in CDH1-2,3P cln1,2 cells compared to
CDH1-2,3P cells, although the interpretation of the results might be challenging
due to APC-Cdh1-independent effects on biosensor degradation. Above, I also
propose a few additional experiments to clarify whether deletion of CLN1 and 2
in rescues the phenotype of CDH1-2,3P by restoring mitotic cyclin-CDK activity.

ACM1 is lower on the hierarchy of negative regulators of APC-Cdh1. Deletion of
ACM1 in wild type cells has no obvious growth or morphological defects,
although a previous study has suggested that there might be occasional defects
in nuclear positioning and spindle morphology in acm1 cells (Martinez et al,
2012). Careful time-lapse microscopy experiments using the APC-Cdh1
biosensor might be able to reveal any defects in APC-Cdh1 inactivation in acm1
cells.
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However, deletion of ACM1 was found to be deleterious when Cdh1
phosphorylation is impaired, either by removing a subset of phosphorylation
sites, or deleting the likely main physiological kinases for Cdh1, CLB5 and 6.
This suggests that inhibition by Acm1 likely serves as a buffer for occasional cell
cycles when proper phosphorylation of Cdh1 fails.

I found no genetic interactions between CDH1-2,3P and deletion of MSN5.
Previous experiments also showed no genetic interactions of msn5 deletion with
partially phosphorylatable CDH1 alleles bearing other subsets of
phosphorylation sites (J. Robbins, PhD thesis). Together, this suggests that
Msn5 can promote nuclear export through interacting with multiple different
phosphorylation sites on Cdh1, or that nuclear export of Cdh1 contributes so
little to overall APC-Cdh1 inactivation that eliminating the nuclear export does
not have any effects on cell viability. To assess the localization of Cdh1 protein
throughout the cell cycle in partially phosphorylatable CDH1 mutants, I
attempted to construct a GFP-tagged version of CDH1; however, presumably
due to low endogenous expression levels of CDH1, even when tagged with
three repeats of fluorescent protein, the GFP signal was undetectable (data not
shown). Overall, I therefore cannot evaluate the significance of nuclear export to
APC-Cdh1 inactivation.
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Chapter 5: Global analysis of cell cycle-regulated gene expression

The cell cycle progression in budding yeast is tightly linked to changes in gene
expression, as approximately 20% of the yeast genome exhibits once per cell
cycle oscillations of mRNA abundance. The main challenge at the present point
is to understand to what extent this periodic gene expression is regulated by
cyclin-CDK activity and therefore downstream of the CDK oscillator, and to what
extent periodic gene expression is controlled by a “transcriptional oscillator”,
which was proposed to operate independently of the CDK oscillator (Orlando et
al, 2008; Simmons-Kovacs et al, 2012).

In order to address this question, gene expression was measured in a strain
where all cyclins were deleted and replaced with exogenously controlled G1 and
mitotic cyclin. In this strain, tight control of cyclin expression allowed for
complete depletion of all cyclin-CDK activity. A genome-wide gene expression
time course experiment was performed and analyzed by principal component
analysis. The experimental part of this work was done in collaboration with S.
Jamal Rahi and Kresti Pecani.
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5.1. Construction of strains and the time course experiment

For this experiment, two yeast strains were used. The experimental strain,
named cln-clb-, had all three G1 cyclins CLN1,2,3 deleted and replaced with a
copy of CLN2 driven by methionine-repressible promoter MET3. In addition, all
the B-type cyclins CLB1-6 were also deleted, and replaced by galactoseinducible CLB2 (GALL-CLB2). The control strain, named cln-CLB+, also had the
G1 cyclins deleted and replaced by MET3-CLN2, but retained all the CLB
cyclins. The cln-clb- strain was viable on G-Met media where both CLN2 and
CLB2 were constantly expressed, indicating that periodic gene expression of
cyclins is not essential for cell cycle progression, even though the levels of Clb2
protein and Clb2-CDK kinase activity was substantially higher than in cyclin wild
type cells in the same media condition (Rahi et al, submitted).

The previous experiment where gene expression in absence of B-type cyclins
was measured (Orlando et al, 2008) was done in a strain where GAL1-CLB1
was replacing all the B-type cyclins, but the activity of residual Clb1 upon shutoff
was not measured, and it is possible that due to high expression level of GAL1
promoter, residual CLB1 could be present and could affect gene expression. For
our cln-clb- strain, a protocol was devised in which the cells can be arrested in
G1 completely depleted of any Clb2-CDK activity (1-2% of the wild type peak of
total Clb-CDK activity; Rahi et al, submitted).
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cln-CLB+

D-met

D+met
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D+met
240
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cln-clb-

Figure 5.1: The scheme of the time course experiment for gene expression
dynamics. Both cln-CLB+ (control) and cln-clb- cells were synchronized as
unbudded cells in G1 by depleting G1 cyclins. -Met pulse for 90 minutes allowed
expression of Cln2 and budding in both cells. cln-CLB+ cells proceeded to
complete the cell cycle and arrested in subsequent G1 phase. cln-clb- cells were
arrested at the G1/S border due to absence of B-type cyclins. Samples for
transcriptome analysis were taken every 30 minutes. D, glucose; met,
methionine.
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The graphic scheme of the time course experiment is depicted in figure 5.1.
Upon G1 arrest in Glu + met media where Clb2 was completely depleted (t=0 in
the experiment), both strains were transiently shifted to media without
methionine to transiently express MET3-CLN2 for 90 minutes, after which
methionine was added back to turn MET3-CLN2 off. The transient expression of
CLN2 allowed for bud emergence in both strains. The control strains cells
continued the cell cycle unperturbed until the next G1 phase, when they again
arrested due to absence of G1 cyclins. Cln-clb- cells arrested after the transient
-Met pulse as budded cells at the G1/S border, as their cell cycle progression
was blocked due to absence of Clb-CDK activity. Aliquots of cultures were
collected every 30 minutes and mRNA was isolated for transcriptome
sequencing.

5.2. Dynamic transcriptional activity of cell cycle-regulated transcripts

Visual inspection of selected genes, previously associated with cell cycle
regulation, revealed the dynamics of cell cycle regulons. The genes in the G1/S
regulon, regulated by transcription factors SBF and MBF, peaked at 60 minutes,
and the transcript abundance promptly decreased after (Figure 5.2 A). Both
TOS6 (a SBF target), as well as RAD53 (an MBF target) also peaked in the clnclb- cells.
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Figure 5.2: Transcript abundance of representative cell cycle-regulated genes.
A; G1/S regulon. B; G2/M regulon (CLB2 cluster). C; M/G1 regulon (SIC1
cluster). D; histone cluster. E; S-phase cluster.
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The genes from the second main regulon, the CLB2 cluster (Spellman et al,
1998), regulated by the complex of Mcm1, Fkh1/2 and Ndd1 (Koranda et al,
2000; Reynolds et al, 2003), showed peak transcript abundance at 90 minutes
(figure 5.2 B) in control cln-CLB+ cells. In contrast, no transcript of SWI5 or
CDC20 genes in cln-clb- cells was detected. I note that this is in contrast with
results by Orlando et al (2008), who observed reduced, but not absent activation
of these genes (Orlando et al, 2008). Since requirement of mitotic cyclin activity
for expression of CLB2 cluster genes is well established (Amon et al, 1993),
residual Clb1-CDK activity in the Orlando et al experiment might explain this
discrepancy.

The genes from the late mitotic gene cluster (SIC1 cluster, Spellman et al, 1998)
peaked at t=120 min and t=150 min time points (figure 5.2 C). Interestingly, in
cln-clb- cells, SIC1 (a Swi5 target) expression was observed even though the
amplitude was decreased compared to the control, but no CTS1 (an Ace2
target) expression was observed.

I also examined genes belonging to additional regulatory clusters, the “histone
cluster” (Spellman et al, 1998) and the S-phase cluster, regulated by Hcm1
(Pramila et al, 2006). Genes belonging to both of these clusters were activated
at 60 minutes in control cells (Figure 5.2 D,E), making them indistinguishable in
timing from the G1/S genes in this experiment due to limited time resolution.
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Both HTA1 (from the histone cluster) and WHI5 (from the S-phase cluster) were
also activated in cln-clb- cells with reduced amplitude.

5.3. Principal component analysis of the gene expression dataset

In order to gain insight into the global patterns of gene expression and global
differences between the cln-CLB+ and cln-clb- cells, I performed principal
component analysis (PCA) on the dataset in the matrix A. A is a 6717x16
matrix, each row representing one gene, and each column one time point
sample (8 time point samples for each control and cln-clb- strain were collected).
Preprocessing of the dataset to generate A is described in chapter 7 (Materials
and methods).

PCA (also sometimes called singular value decomposition (SVD)) is a statistical
method that produces a set of mutually orthogonal principal components. PCA is
a commonly used procedure to reduce the dimensionality of the data by focusing
on the main principal components that explain most of the variance. The
transformation of the gene expression dataset matrix A according to the
equation A=USVT yields a set of 16 principal components, which are sets of
uncorrelated, mutually orthogonal vectors, contained in matrices U and V.
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The set of vectors in U represents “eigengenes”, an orthonormal set of vectors
that explain variance among the genes (mathematically, eigengenes are
eigenvectors of the covariance matrix ATA). The set of vectors in V represents
“eigensamples”, an orthonormal set of vectors that explains the variance among
the time point samples (mathematically, eigenvectors of the covariance matrix
AAT).

The first four principal components explain 50% of the total variance (table 1) of
the dataset. The first two principal components each explain about 15% of the
variance. The mathematics of the PCA suggests focusing on the principal
components that explain a higher fraction of variance.

Here, I plot the time profiles of the first four eigengenes. The profile of the first
eigengene shows a different pattern between the control and cln-clb- strains
(figure 5.3). For the control strain, it showed a broad peak at timepoints from 90
to 180 minutes. For the cln-clb- strain, it remained constant at low levels for the
entire experiment. In contrast, the second eigengene showed a very pattern for
both strains, with both the control and cln-clb- strains exhibiting a sharp peak at
the 60 minutes timepoint.
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Figure 5.3: Time profiles of eigengenes associated with the four highest singular
values.

Principal component
1
2
3
4
Sum (5-16)

Fraction of variance explained
0.15
0.15
0.11
0.08
0.51

Table 5.1: Fraction of variance explained by individual principal components.
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The third and fourth eigengenes, which explain 11 and 8 % of variance in the
dataset, respectively, also showed different dynamics for the control and cln-clbstrain, with peaks and troughs at different timepoints. Further analysis was
focused on first two principal components.

5.4. Clustering of co-regulated genes in the eigengene space

Gene profiles for each individual gene were projected onto the subspace
spanned by the first two principal components, and combined that with
functional classification of genes based on published information on their
transcriptional regulation (Figure 5.4).

On the scatter plot, genes from the dataset of annotated SBF and MBF targets
(Ferrezuelo et al, 2010) are plotted in green. On the PC1/PC2 subspace, genes
from this regulon are largely clustered along the PC2 axis, implying high
correlation of their profiles with the eigengene 2 (figure 5.4).
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Figure 5.4: Projections of genes onto the subspace of the first two eigengenes.
Each dot represents one of the genes (total 6717). Green, genes identified as
SBF and MBF targets. Blue, genes from the CLB2 cluster. Red, genes from the
SIC1 cluster.
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Genes identified as members of the “CLB2 cluster” and “SIC1 cluster” (Spellman
et al, 1998) were plotted in blue and red, respectively. Both of these gene
clusters localized in the region of high correlation with PC1 (figure 5.4).
However, the two clusters were separated from each other. The CLB2 cluster
genes were observed in the upper right area in the region with slightly positive
contribution of the PC2. The SIC1 cluster genes were located below in the
region with slightly negative contribution of PC2.

This results suggests that projecting genes onto the subspace spanned by the
first two principal components generates clusters of co-regulated genes, which
provides validation of the analysis based on the first two principal components.
Further work could be done to analyze other groups of genes based on known
transcriptional co-regulation, as well as groups of genes based on other
functional categories.

5.5. Projection onto eigensample space reveals global gene expression
trajectories

Plotting of projections of successive time point samples onto the subspace of
eigensamples 1 and 2 revealed differences between the cln-CLB+ control and
cln-clb- datasets (figure 5.5). Overall, the trajectories of the two time courses are
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Figure 5.5: Projections of samples onto the subspace of the first two
eigensamples. Numbers on the plot indicate time points in minutes. Red; clnCLB+ samples. Blue; cln-clb- samples.
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strongly separated along the PC1 axis. The time course of the control strain
(figure 5.5, red line) started close to the origin. Subsequently, the contribution of
the second principal component increased strongly at t=60min time point,
followed by an increase of the contribution of the PC1 while the contribution of
the PC2 decreased, and ultimately returned to the starting point to form a closed
orbit. This is consistent with a near-complete return of the cells to the starting
condition of the experiment.

The time course of the cln-clb- dataset (figure 5.5, blue line) initially paralleled
the control time course trajectory. However, the increase of the contribution of
PC2 at the 60 minute timepoint was smaller. After the 60 min timepoint, the clnclb- dataset diverged drastically from the control dataset, immediately returning
close to the starting condition at t=90 min and remained there.

This result has a biological interpretation and implies differential patterns of
global gene expression between the control and cln-clb- cells. The global gene
expression between the cln-CLB+ and cln-clb- strains changed dramatically
starting at the t=90 minutes, corresponding to the timing of the expression of the
CLB2 cluster regulon. Therefore, expression of later cell cycle-transcriptome
after the 60 minute time point is significantly affected in the cln-clb- strain.
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5.6. Conclusions and further directions

Here, I describe a preliminary attempt to analyze the genome-wide gene
expression pattern using principal component analysis. The main motivation was
to compare gene expression pattern of the strain that was lacked all the B-type
cyclins with a control strain. PCA was used before to analyze the budding yeast
cell cycle gene expression data (Alter et al, 2000), and more recently also to
analyze diurnal gene expression in green alga Chlamydomonas reinhardtii (Tulin
and Cross, submitted). Unlike other methods used before to analyze gene
expression patterns, such as k-means clustering (Eisen et al, 1998) or
identifying cell cycle-regulated gene expression patterns by comparing with
idealized gene profiles (de Lichtenberg et al, 2005; Orlando et al, 2008), PCA
does not require input of any arbitrary parameters and is model-independent.

Generally, individual eigengenes are only expected to directly reflect some
underlying biological pattern in case the biological patterns are mutually
orthogonal. This, in general, depends strongly on the nature of the data, and can
also be affected by preprocessing of the data.

I analyzed the data in terms of the first two principal components, which together
explain 30% of the variance of the dataset. I find that the G1/S regulon genes
correlate strongly with the second principal component, whereas the later
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expressed gene regulons (CLB2 cluster and SIC1 cluster) correlate with the first
principal component. In the subspace spanned by the first two principal
components, the three main cell cycle gene regulons occupy distinct clusters.

Furthermore, the analysis provides a clear insight into the effects of B-type
cyclins on the gene expression patterns. Contrary to previous analysis, which
highlighted the lack of change in gene expression patterns in cells without Btype cyclins (Orlando et al, 2008), principal component analysis of the present
dataset revealed effects of B-type cyclin deletion. Analyzed in terms of the
subspace of the first two principal components, the gene expression patterns of
the control and cln-clb- strain diverged greatly after 60 minutes, indicating that
the gene expression of later genes, but not the G1/S regulon, is affected in the
B-type cyclin mutant cells.

Presently, the focus was on the first two principal components, which was
sufficient to explain the main patterns in the dataset, and the additional principal
components were ignored. Principal components that explain smaller degree of
variance are generally assumed to only reflect noise in the dataset; however,
analyzing the data in terms of additional principal components might reveal
additional details about the experiment. In addition, further insights might be
gained by improving the temporal resolution of the experiment; while 30 minute
sampling interval is sufficient for temporal differentiation of the three major
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regulons, finer sampling might reveal subtler temporal differences in expression
between genes in the same regulon, and changes in timing between control and
cln-clb- cells.
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Chapter 6: Discussion

Timing of APC-Cdh1 inactivation

In this work, I measured the timing of APC-Cdh1 inactivation at the single cell
resolution.

The events associated with the Start transition in budding yeast were previously
shown to be relatively coherent, with some coherence between the events likely
sacrificed to ensure timely completion of all events (Bean et al, 2006).
Inactivation of APC-Cdh1, as shown here, is highly coherent with Whi5 exit, but
poorly coherent with bud emergence. This is, as shown before, due to
substantial variability of timing of bud emergence with respect to Whi5 exit (Di
Talia et al, 2007).

Whi5 exit is the regulatory step that ensures expression of multiple genes that
contribute to APC-Cdh1 inactivation; which subcomponents of the Start
regulatory network contribute to timely APC-Cdh1 inactivation remains to be
addressed.

I speculate that the difference in observed timing variability between APC-Cdh1
inactivation and bud emergence might be rationalized by differential selection
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pressure for reducing variability. The timing variability in bud emergence might
be tolerated because budding is regulatorily decoupled from downstream cell
cycle events, and bud growth is likely not rate limiting for cell cycle progression.
In contrast, inactivation of APC-Cdh1 is an essential step for immediate
downstream events, such as accumulation of mitotic cyclins, and, as also shown
in this work, activation of expression of the mitotic cyclins. Therefore, a delay in
APC-Cdh1 inactivation could be rate-limiting for subsequent cell cycle events.
The architecture of the Start molecular network has likely been designed to
prioritize noise suppression in inactivation of APC-Cdh1 over bud emergence.

Requirement for multisite phosphorylation of Cdh1 for APC-Cdh1
inactivation

The experiments presented here contribute to our understanding of how the
multisite phosphorylation of Cdh1 works. Previously, it has been shown that no
single site is essential, and that contribution of phosphorylation sites is unequal,
implying regulation by bulk charge with some regional specificity (J. Robbins,
PhD thesis). Here, I further show that no single phosphorylation site is sufficient
for proper inhibition of APC-Cdh1 activity.
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Multiple partially phosphorylatable CDH1 mutants showed stochastic cell cycle
defects in individual cells. Further characterization of the phenotype of one of
these mutants revealed a partially penetrant phenotype in cell cycle progression.
A fraction of the cells completed the cell cycle, and even the cells that
resembled the fully arrested cells continued to perform some cell cycle events.
This phenotype was, as measured using the assay for APC-Cdh1 activity,
associated by incomplete but partial restrainment of APC-Cdh1 activity.
However, due to the complex phenotype, precise quantification of the
requirement for APC-Cdh1 inactivation remains unknown.

Mechanism of APC-Cdh1 inactivation by phosphorylation at the N-terminal
sites

A high-resolution of structure of the APC bound to Cdh1 has revealed the
interface between Cdh1 and APC (Schreiber et al, 2011). Notably, the Nterminal sites, which were shown to have the strongest contribution to APCCdh1 inactivation, are located in the unstructured region of Cdh1 that maps into
the unassigned density in the structure that likely links Cdh1 and the C-terminus
of Apc2 (Schreiber et al, 2011; D. Barford, personal communication), implying a
direct physical interaction of the N-terminus of Cdh1 with Apc2. This structural
detail might provide an insight into the biochemical mechanism of inhibition by
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phosphorylation at the N-terminal sites, and further biochemical experiments
could be designed to test this directly.

Cyclin specificity in Cdh1 phosphorylation

Here, I add two additional pieces of evidence that suggest that Cdh1 might be
predominantly phosphorylated by Clb5-CDK (and possibly its less potent partner
Clb6-CDK) in vivo. Multiple lines of evidence for the role of Clb5-CDK already
exist. Substrate specificity of Clb5-CDK is determined by presence of the RXL
motif on the substrate; such a motif exists in Cdh1, and Cdh1 was preferentially
phosphorylated by Clb5-CDK compared to Clb2-CDK in cell lysates (Loog and
Morgan, 2005).

Here, I show that in absence of Clb5 and 6, inactivation of APC-Cdh1 is
delayed. This result was shown by measurement in single cells and the delay
was quantified; however a qualitative observation of the delay in APC-Cdh1 in
absence of Clb5 and 6 has been shown before (Huang et al, 2001). This
indicates that Clb5 and/or 6-CDK are likely the physiological kinase for Cdh1 in
wild type cells, although in their absence, other kinases can carry out
physiologically sufficient Cdh1 phosphorylation with a delay or with reduced
efficiency.
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Second, deletion of CLB5 was shown to be lethal in combination of mutation of
either the C-terminal or N-terminal sites. The likely interpretation of this result is
that when phosphorylation of Cdh1 becomes impaired, other kinases become
insufficient for efficient or timely phosphorylation at the remaining sites, implying
a strong contribution of Clb5-CDK to phosphorylation of both of these subsets of
sites. However, this genetic interaction can also be interpreted by indirect effects
of clb5 deletion.

In contrast, assessing the role of Cln1 and 2-CDK in APC-Cdh1 inactivation
revealed an opposite result, as deletion of CLN1,2 in partially phosphorylatable
CDH1 context paradoxically alleviated the phenotype associated with
incomplete APC-Cdh1 inactivation. This result is at present difficult to reconcile
with the current understanding of the budding yeast cell cycle control. This
genetic interaction does not exclude the possibility that any phosphorylation of
Cdh1 by Cln1,2-CDK occurs; however, it points at that another additional
mechanism of APC-Cdh1 regulation by Cln1,2-CDK that is presently not
understood. Further characterization is required to understand the mechanism of
the rescue and explain the complete role of Cln1,2-CDK in APC-Cdh1
regulation.
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The global cell cycle transcriptional program requires B-type cyclins

I addressed the global cell cycle regulatory program. The current unresolved
controversy is to what extent cell cycle-regulated transcription is, like the
majority of other cell cycle events, regulated by oscillations of cyclin-CDK
activity, and to what extent the periodic transcriptional program is autonomously
driven by a proposed transcription factor oscillator (Orlando et al, 2008;
Simmons-Kovacs et al, 2012).

To address the question, I performed principle component analysis on the global
gene expression dataset generated from the time course of cells lacking all Btype cyclins, along with control cells. The results of the principal component
analysis showed that the global transcriptional pattern is largely absent in B-type
cyclin mutant cells. This result implies the requirement for B-type cyclin-CDK
activity for the global periodic transcriptional program.

However, it must be noted that the absence of a global pattern of periodic gene
activation does not preclude that some individual genes might still be activated
in absence of Clb-CDK activity. In fact, a small subset of M/G1 genes, most
notably including SIC1, a gene coding for an inhibitor of B-type cyclin kinases,
was found to be expressed in absence of Clb-CDK activity. Given the function of
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Sic1 in the budding yeast cell cycle, a mechanism for Clb-CDK-independent
transcriptional induction has been proposed (Rahi et al, submitted).
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Chapter 7: Materials and methods

Strains and plasmid construction

Standard methods for strain constructions were used throughout. All strains are
W303-congenic. Strains and plasmids used in this work are listed in tables 7.1
and 7.2, respectively. The APC-Cdh1 biosensor plasmid was constructed by
amplifying the ASE1 degron sequence from the plasmid PB1452 (obtained from
David Pellman) and cloned into the pGC25 plasmid to obtain pAO4, which was
linearized with XbaI to integrate into the TRP1 locus. The following
oligonucleotides were used for cloning:
Ase1degr-f-COR:
GGTATTACCCATGGTATTGATGAATTGTACAAAAGATCTAAAAAGGGAAAAT
GTGGTGCG
Ase1degr-r:
TCGCTTATTTAGAAGTGGCGCGCCTTATCAAATATCTGTAAAGGAGAATCCA
TTC
The pAO1, pAO2 and pAO3, pAO16-23P and pAO16-13P plasmids bearing
CDH1 phosphomutants were generated by subcloning AvaI/BlpI fragments
(containing the N-terminal parts of the CDH1 ORF) from JRP64, JRP63, JRP62,
JRP60 and JRP78, respectively, into FC687. The plasmid was then linearized
with BglII to integrate into the CDH1 locus. The transformants were then
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subjected to 5-FOA selection. This generated colonies of both wild-type CDH1
and desired phosphomutant depending on the site of homologous
recombination; colonies were screened by sequencing the PCR product.

Media and culture conditions

Standard media and liquid culture conditions were used. Fluorescence imaging
experiments were performed with cultures grown in synthetic media to minimize
autofluorescence.

Fluorescence time-lapse microscopy and image analysis

Time lapse imaging and subsequent automated image segmentation was
performed using the instrumentation and software as described previously
(Charvin et al, 2008), with a difference that cells grown in a commercial
microfluidic chamber (CELLAsic, Hayward, CA) as per manufacturer
instructions. Images were acquired every 3 minutes. Subsequent data analysis
was performed in Matlab. Image segmentation was done semi-automatically.
Fluorescence trace smoothing was performed using the Matlab function
“smooth” with the method “lowess” over the 10 time points. Nuclear fluorescence
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was measured by either manually detecting nuclei from the images, or
computed from the images as described (Charvin et al, 2010). In experiments
using both GFP and YFP, fluorescence in both channels was recomputed to
correct for spectral bleed-through using empirically determined parameters.

DIC microscopy

DIC images were taken using an Axioplan 2 microscope (Carl Zeiss,
Thornwood, NY) and a 63x NA 1.4 Plan APO objective. The camera and the
microscope were controlled by the OpenLab software.

Immunoblotting

Immunoblots were performed using standard protocols. The antibodies (rabbit
polyclonal anti-Clb2 and anti-Pgk1 (Invitrogen, Carlsbad, CA)), were used in
1:10000 concentrations. Enhanced chemiluminescence signal was measured
with DarkBox (Fujifilm, Greenwood, SC) with a charge-coupled device camera
and quantified using MultiGauge software (Fujifilm). Quantification was
performed using ImageJ.
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Transcriptome analysis

Total RNA was isolated from collected samples using the Trizol reagent. cDNA
libraries were prepared using Illumina TruSeq sample preparation kit.
Sequencing was performed by Genewiz (South Plainfield, NJ) and was done on
the Illumina HiSeq2500 platform in a 1x50bp single-read configuration in Rapid
Run mode.

Data preprocessing

The mRNA sequencing data were expressed as fpkm (fragments per kilobase
per million reads). The reads for each strain and time point were normalized to
the same total reads. The time course was performed in biological duplicates;
the datasets were normalized to each other before averaging. The matrix
contained 6717 rows, each corresponding to one gene, and 16 columns,
corresponding to time point samples (8 for the cln-CLB+ control, 8 for the clnclb-). Before performing PCA, each row was normalized by mean expression
and subtracted 1 to center each gene profile at 0. Finally, genes with mean
expression below 3 fpkm were filtered out; these low fragment counts are almost
surely not biologically relevant, and noise from these random fluctuations was
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found to significantly dominate the principal component analysis if not filtered
out. This generated the data matrix A.

Principal component analysis

Principal component analysis was performed in Matlab using the command svd,
which generated 3 matrices according to the equation A=USVT, where A is the
matrix containing the gene expression data. The matrix S is a diagonal matrix
containing singular values (weights of each principal component). The matrix U
contains column vectors, “eigensamples”, that are eigenvectors of the
covariance matrix AAT. Finally, the matrix V contains column vectors,
“eigengenes”, that are eigenvectors of ATA.

Projections of genes onto the subspace of the first two principal components
were calculated as dot products of rows of the matrix A with the first two
eigengenes (for the figure 5.4). The projections of samples were calculated as
dot products of each column of the matrix A with the two eigensamples.
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Table 7.1: List of strains used in this work.
GC46-03
AO832-3c
AO852-2d
AO602-11d
AO95-4a
AO261-5b
AO1221-12c
AO7-1p1
AO7-2p2
AO7-3p3
AO17-13P1
AO17-23P
3149-21
AO761-8b
AO812-12c
AO87-4c
AO712-11c
AO64-1c
AO632-6c
AO70-6d
AO632-4b
yLB5
AO72-5c
AO681-1c
AO86-6b
JRC397A-1c

MATa MYO1-mCherry-HIS5
MATalpha MET3pr-yVENUS-ASE1deg-TRP1::trp1 MYO1mCherry-HIS5
MATalpha MET3pr-yVENUS-ASE1deg-TRP1::trp1 MYO1mCherry-HIS5 cdh1::LEU2
MATa MET3pr-yVENUS-ASE1deg-TRP1::trp1 GALLCDC20-ADE2::ade2 cdc20::LEU2
MATalpha MET3pr-yVENUS-ASE1deg-TRP1::trp1 MYO1mCherry-HIS5 GALL-ACM1-LEU2::leu2 CDH1-m11
MATa MET3pr-yVENUS-ASE1deg-TRP1::trp1 WHI5-GFPKanMX HTB2-mCherry-HIS5
MAT? MET3pr-yVENUS-ASE1deg-TRP1::trp1 MYO1mCherry clb5::HIS3 clb6::KanMX
MATa GALL-ACM1-LEU2::leu2 CDH1-1P
MATa GALL-ACM1-LEU2::leu2 CDH1-2P
MATa GALL-ACM1-LEU2::leu2 CDH1-3P
MATa GALL-ACM1-LEU2::leu2 CDH1-1,3P
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P
MATa GALL-ACM1-LEU2::leu2 CDH1-m11
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P MYO1mCherry-HIS5 MET3-yVENUS-ASE1deg-TRP1::trp1
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P MYO1mCherry-HIS5 CLB2-GFP-HIS5
MATa GALL-ACM1-LEU2::leu2 CDH1-m11 MYO1mCherry-HIS5 CLB2-GFP-HIS5
MATa GALL-ACM1-LEU2 MYO1-mCherry-HIS5 CLB2prGFP-KanMX CDH1-2,3P
MATalpha GALL-ACM1-LEU2 MYO1-mCherry-HIS5
CLB2pr-GFP-KanMX CDH1-m11
MATa GALL-ACM1-LEU2 MYO1-mCherry-HIS5 SIC1prYFP-URA3 CDH1-m11
MATalpha GALL-ACM1-LEU2 MYO1-mCherry-HIS5
SIC1pr-YFP-URA3 CDH1-2,3P
MATa GALL-ACM1-LEU2 MYO1-mCherry-HIS5 SIC1prYFP-URA3
MATa MYO1-mCherry-HIS5 CLN2pr-GFP-URA3
MATa GALL-ACM1-LEU2 MYO1-mCherry-HIS5 CLN2prGFP-URA3 CDH1-m11
MATa GALL-ACM1-LEU2 MYO1-mCherry-HIS5 CLN2prGFP-URA3 CDH1-2,3P
MATa MYO1-mCherry-HIS5 CLB2-GFP-HIS5
MATa GAL1-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3
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JRC397A-9b
JRC397A-9b
MNX33-1d
MNX33-3c
MNX33-7d
AO88-10a
AO88-7c
AO88-10b
AO89-7b
AO89-10a
AO89-11b
JRC437A-6a
JRC437A-4d
JRC437A-9c
JRC436A-6c
JRC436A-1c
JRC436A-1d
AO1272-7d
AO1272-2d
AO1271-5b
AO1271-5a
AO1192-9a
AO1194-6b
AO939-7b
AO939-7a
AO1017-3d
AO1012-10b
AO123-4a
AO123-7a

MATa GAL1-ACM1-URA3::ura3 acm1::KanMX
MATa GAL1-ACM1-URA3::ura3 msn5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P
acm1::KanMX msn5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P msn5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P
acm1::KanMX
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P acm1::KanMX
msn5::HIS3
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P acm1::KanMX
MATalpha GALL-ACM1-LEU2::leu2 CDH1-2,3P
msn5::HIS3
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P clb6::KanMX
clb5::HIS3
MATa GALL-ACM1-LEU2::leu2 CDH1-2,3P clb6::KanMX
MATalpha GALL-ACM1-LEU2::leu2 CDH1-2,3P clb5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P clb6::KanMX
clb5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P clb5::HIS3
MATa GAL1-ACM1-URA3::ura3 CDH1-5:11P clb6::KanMX
MATa GAL1-ACM1-URA3::ura3 clb5::HIS3
MATa GAL1-ACM1-URA3::ura3 clb6::KanMX
MATa GAL1-ACM1-URA3::ura3 clb6::KanMX clb5::HIS3
MAT? GALL-ACM1-LEU2::leu2 clb6::KanMX clb5::HIS3
acm1::NatMX
MAT? GALL-ACM1-LEU2::leu2
MAT? GALL-ACM1-LEU2::leu2 clb6::KanMX clb5::HIS3
MAT? GALL-ACM1-LEU2::leu2 acm1::NatMX
MATa GALL-ACM1-LEU2::leu2 MET3-CLN2-TRP1::trp1
MYO1-mCherry-HIS5
MAT? GALL-ACM1-LEU2::leu2 MET3-CLN2-TRP1::trp1
cln1 cln2 MYO1-mCherry-HIS5
MATa GALL-ACM1-LEU2::leu2 MET3-CLN2-TRP1::trp1
CDH1-2,3P
MATa GALL-ACM1-LEU2::leu2 MET3-CLN2-TRP1::trp1
CDH1-2,3P cln1 cln2 MYO1-mCherry
MAT? GAL1-ACM1-URA3::ura3 MET3-CLN2-TRP1::trp1
CDH1-5:11P cln1 cln2
MAT? GAL1-ACM1-URA3::ura3 MET3-CLN2-TRP1::trp1
CDH1-5:11P
MAT? GALL-ACM1-LEU2::leu2 GAL1-SIC1-TRP1::trp1
CDH1-2,3P CLB2-ken
MAT? GALL-ACM1-LEU2::leu2 GAL1-SIC1-TRP1::trp1
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AO123-5d
AO1261-3b
AO-44-4
AO-1271-5a
AO-1271-5b
AO-1272-2d
AO-1272-7d
2773-1D
SJR27a7b

CLB2-ken
MAT? GALL-ACM1-LEU2::leu2 GAL1-SIC1-TRP1::trp1
CDH1-2,3P
MAT? GALL-ACM1-LEU2::leu2 MET3-yVENUS-ASE1degTRP1::trp1 MYO1-mCherry-HIS5 CDH1-2,3P CLB2-ken
MATa MYO1-mCherry-HIS5 CLB2::CLB2pr-GFP-LEU2
MAT? GALL-ACM1-LEU2 acm1::NatMX
MAT? GALL-ACM1-LEU2 clb5::HIS3 clb6::KanMX
MAT? GALL-ACM1-LEU2
MAT? GALL-ACM1-LEU2 clb5::HIS3 clb6::KanMX
acm1::NatMX
MATa cln1 cln2 cln3::LEU2 MET3-CLN2-TRP1
MAT? cln1 cln2 cln3::LEU2 MET3-CLN2-TRP1 clb1
clb6::KanMX clb2::GAL-CLB2-URA3 clb5::KanMX
clb3::TRP1 clb4::his3::KanMX SIC1::SIC1pr-YFP-URA3

Table 7.2: List of plasmids used in this work.
pAO4
PB1452
pGC25
pAO1
pAO2
pAO3
pAO16-23P
pAO16-13P
FC687
JRP64
JRP60
JRP63
JRP62
JRP78

pRS404 MET3pr-Ase1deg-VENUS
GAL1-ASE1degron-GST
pRS404 MET3pr-VENUS
pRS406 CDH1-1P
pRS406 CDH1-2P
pRS406 CDH1-3P
pRS406 CDH1-2,3P
pRS406 CDH1-1,3P
pRS406 CDH1-m11
pRS406 CDH1-S16A-T42A-T157A
pRS406 CDH1-T12A-T157A
pRS406 CDH1-T12A-T42-T157A
pRS406 CDH1-T42-T157A
pRS406 CDH1-S16A-T157A
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